Report #10

Comprehensive Spinoff Investment Opportunities

21 active graded separations tracked after two removals (New Fortress, ABVC). Corteva → Vylor went through on schedule after California and 18 other states sought to enjoin it as a fraudulent transfer, and Modine's Performance Technologies closed into Gentherm — both on October 1, the day after pricing, so both remain upcoming in this edition. KBR's Trinzic Form 10 is a downgrade, B+ (3.40) to B (2.95); Flex's Axiom (AXM) and Genuine Parts' Motion are upgraded to B+ (3.35). MiniMed's split-off exchange offer runs to October 9 and MSG Rangers distributes October 26. September was the completed cohort's worst month on record: 5 of 25 rose, with new post-spin lows at ADIG, MBGL, FDXF and HONA. Five first grades come in from the standing company profiles.

COMPREHENSIVE SPINOFF INVESTMENT OPPORTUNITIES

Upcoming Spinoffs Over Next 12 Months (October 2026 - October 2027)

Analysis Date: September 30, 2026 Pricing Date: All stock prices as of September 30, 2026 close (verified daily data via yfinance) unless otherwise noted.

Dating convention. From this edition the report is dated at its pricing date and is right as of that date. Two separations completed on October 1, the day after pricing — Corteva → Vylor and Modine’s Performance Technologies → Gentherm. Both remain upcoming in this edition’s tables; their completions are noted where they appear and they move to Part 3 in the next report.


EXECUTIVE SUMMARY: KEY CHANGES SINCE LAST REPORT (August 31, 2026)

Completed Since Last Report

ParentSpinCoTickerDistribution DateCurrent Status
New Fortress Energy (NFE)BrazilCo / CoreCoNFE (CoreCo)September 11, 2026✅ Restructuring and separation completed. BrazilCo went 100% to creditors — NFE shareholders received no BrazilCo shares. Creditors also took 65% of CoreCo; existing holders keep 35%. A 1-for-50 reverse split was effected and CoreCo continues on Nasdaq as NFE. $6.27 on Sep 30, -56.8% for the month on a split-adjusted basis. Removed from tracking — there is no SpinCo for shareholders to own.
ABVC BioPharma (ABVC)BioKey (Cayman)(no symbol)August 21, 2026✅ Completed August 21 — a correction to last edition’s “status unconfirmed.” Only ≈15% of BioKey was distributed (0.169464 BioKey per ABVC share); ABVC keeps control; OTC quotation not yet applied for. Removed from tracking (micro-cap footnote).

Completed the day after the pricing date (October 1) and therefore still carried as upcoming: Corteva → Vylor (VYLR) and Modine Performance Technologies → Gentherm (RMT).

Major Developments

  • ⭐ Corteva/Vylor went through on schedule — after a court fight nobody priced. The board approved the separation on September 12 (8-K September 15): 1 Vylor share per Corteva share, record date September 24, distribution before the open on October 1, NYSE: VYLR; New Corteva keeps CTVA. The Form 10 went effective September 24 and when-issued trading was cancelled the same day. In mid-September California, backed by 18 other states, sought to enjoin the spin as a fraudulent transfer; leave was denied September 15, reversed and remanded by the Fourth Circuit, and the injunction denied on remand on September 30 — the day before distribution. The final information statement filled every blank this report flagged: debt at spin $5,668M (2.26x gross / 1.83x net on FY25 EBITDA), a cash distribution to New Corteva of $726–776M on top of ≈$3,078M already moved since July 1, a dividend of ≈15% of operating cash flow starting Q4 2026, and an “Applicable Percentage” of 62% Vylor / 38% New Corteva for shared liabilities — with legacy PFAS staying at New Corteva. A- (3.80) maintained. Vylor’s first regular-way close on October 1 was ≈$69 (post-pricing).
  • ⬇️ KBR’s Trinzic Form 10 is finally public — and it is a downgrade, B+ (3.40) → B (2.95). Filed September 30. Three disclosures the report could not see a month ago: (1) on its own standalone basis Trinzic earned an 8.4% adjusted EBITDA margin in FY2025 and 9.6% in 1H26 — not the 11.4% this report carried, which was KBR’s segment figure before standalone corporate cost; (2) $1,780M of separation debt, of which $1,664M (93%) is paid to KBR — ≈3.6x 1H26 annualised EBITDA and 4.0x FY25; (3) KBR will distribute only “at least 80.1%” and may retain up to 19.9%. This is the debt-loading pattern the report has learned to price. Ticker TZIC; CFO Nicholas Veasey named. Data correction plus new disclosure, not a business change.
  • ⬆️ Flex named its SpinCo, filed its Form 10 and bought it a $4.4B acquisition in the same fortnight. Axiom Solutions International (Nasdaq: AXM) — Form 10 filed September 15. FY2026 (to March 31) net sales $6.61B, +38%; operating income $480M. On September 3 Flex agreed to buy EPC Power for $4.4B (≈$800M of 2026 revenue, ≈30% 2027 EBITDA margin guided) and fold it into Axiom, which will borrow and pay Flex a cash distribution equal to the acquisition debt — pro-forma short-term debt $4.37B. Flex distributes 88–94% and keeps 6–12% for later disposal. The sitting Flex CEO, Revathi Advaithi, and CFO Kevin Krumm both move to Axiom. EGM November 2 (three-quarters vote) plus Singapore High Court approval. Upgraded B → B+ (3.35), provisional on the undisclosed EBITDA and ratio.
  • ⬆️ Genuine Parts put its CEO on the industrial side. On September 9 GPC named Will Stengel, its chairman and CEO, as Chairman and CEO of Motion — the industrial SpinCo keeps the Motion name — with James Howe as President & COO and Howard Yu (ex-Ball CFO) as CFO. RemainCo GPC hires an outside CEO, Court Carruthers. When the sitting CEO follows the SpinCo, the methodology reads it as the parent’s view of where the value is. Investor days December 8–9. Upgraded B → B+ (3.35), provisional — no Form 10 yet.
  • ⭐ Medtronic launched the MiniMed split-off on September 14. An exchange offer for up to 225,361,295 MMED shares (80.1%) at a 7% discount (≈$107.53 of MMED per $100 of MDT tendered, capped at 4.5939 MMED per MDT share), with the remaining 27.45M shares added if oversubscribed. Pricing October 5–7, expiry October 9. This moves a name the report carried at “by April 2027” into the immediate window. MiniMed’s Q1 FY27 sales were $843M, +17%, with guidance raised.
  • ⭐ MSG Sports set the Rangers dates. Board approval September 30: record date October 20, distribution October 26, regular-way MSGR and MSGK from October 27; ratio unchanged at 1-for-2. Final NHL approval and Form 10 effectiveness remain outstanding. B (2.60) maintained.
  • Modine/Gentherm cleared every gate and closed October 1. The Gentherm vote on September 10 passed with 99.97% of votes cast for the share issuance; the IRS ruling and all regulatory approvals were received. Terms were revised September 17: more Gentherm shares to Modine holders (≈2.9M extra), offset by cutting SpinCo’s cash payment to Modine from $210M to $159M and a $1.90/share Gentherm special dividend. Former SpinCo holders end with ≈43.6%. Modine will rename itself Modexus Solutions. B+ (3.20) maintained.
  • ⚠️ J&J is reportedly in talks to sell DePuy Synthes to Apollo for close to $20B (Bloomberg, September 14). Nothing from J&J. If it happens, the third-largest upcoming orthopedics separation becomes a sale and leaves the tracker.
  • ⚠️ Barrick’s North American IPO is slipping. CEO Mark Hill said on September 29 the IPO may “slide into January”; Bloomberg reported a 2027 delay was under consideration. B+ (3.25) maintained, date flagged.
  • ⚠️ September was the cohort’s worst month in this report’s history. Only 5 of 25 tracked completed spinoffs rose, against an S&P 500 down just 0.6% (SPY $767.05 → $762.63). Four names set new post-spin lows — ADIG $17.92, MBGL $17.15 and FDXF $109.38, all on September 30, and HONA $151.58 on September 9. Most had no company news (Part 3).
  • ⚠️ Comcast fell 18.3% on broadband, not on media. CFO Jason Armstrong said at Goldman’s Communacopia (September 9) that broadband subscriber losses would not ease in Q3; KeyBanc moved to Underweight and UBS cut its target. The NBCUniversal split was reaffirmed for mid-2027. Versant fell 22.9% alongside, through the profile’s own $33 accumulate line — rating moved HOLD → ACCUMULATE.
  • 🆕 Five first grades and two rating changes come in from the standing company profiles, written between September 8 and 29 from the filings: Everus Construction (ECG) B+ (3.18) HOLD, South Bow (SOBO) B (2.90) HOLD, Amentum (AMTM) B (2.73) BUY, Versant (VSNT) B (2.75) and Octave (OCTV) B, with Octave’s rating cut BUY → HOLD on its audited three-year record. ADI Global is re-scored B (2.80) → B (2.73) within band. Everus, South Bow and Amentum are added to Part 3.
  • ⚠️ Honeywell Aerospace picked up three governance items in one month: a $2.04M DOJ False Claims Act settlement (September 1) over cybersecurity compliance on a defense contract, removal from the S&P 100 (effective September 21), and a securities class action (class period June 29 – September 1) alleging the probe was not disclosed. None changes the numbers; together they are a Management & Governance question for the next profile pass. B+ (3.20) BUY maintained.
  • ⚠️ Atrium Therapeutics (RNA) fell 37.8% — 20.9% on September 8 alone, the day of its Wells Fargo fireside chat — with no company announcement. It now sits -43.9% vs Day 1, the worst return in the tracked set, and the pre-acquisition-spin thesis August briefly questioned is back on the evidence.
  • Keurig Dr Pepper named its Global Coffee CEO on October 1 (post-pricing): Russ Torres, President & COO of Kimberly-Clark, joins November 3. That closes the gap this report flagged for three months. Grade held at B (2.95) as of the pricing date; the Management dimension is the first thing to re-score next edition.

NEW Spinoffs Added to Tracking

ParentSpinCoAnnouncedExpectedStatus
National Fuel Gas (NFG)Seneca Resources + MidstreamMid-Sep 2026 (reports)Board decision by Oct 15, 2026Strategic review, not yet a spinoff. ≈$5B upstream/midstream business, ≈69% of NFG adjusted EBITDA; sale, merger or spin all under review (Goldman advising). Secondary sources only — no 8-K yet. Exploratory; not graded.
Toro Corp. (TORO)AI OKTO Corp.Sep 9, 2026Record date Oct 1; distribution ≈Oct 8Micro-cap footnote. Greek foreign-private-issuer spin of two LPG carriers plus $45M of cash; 1 AI OKTO per 8 TORO. 20-F registration filed September 9.
Tamarack Valley / Headwater (Canada)Tributary ExplorationSep 8, 2026Q4 2026Non-US, monitored only. Non-core assets spun alongside a ≈C$10B all-stock merger.

Removed / Status Changed

  • New Fortress Energy: completed September 11 as a creditor-led restructuring; removed.
  • ABVC → BioKey: completed August 21 (correction); removed.
  • ⬇️ KBR → Trinzic: B+ (3.40) → B (2.95) on the Form 10.
  • ⬆️ Flex → Axiom (AXM): B → B+ (3.35); named, Form 10 filed, EPC Power added.
  • ⬆️ Genuine Parts → Motion: B → B+ (3.35); GPC’s CEO moves to the SpinCo.
  • ⏩ Medtronic → MiniMed: exchange offer live, expires October 9 — moved from Q1 2027 to Immediate.
  • ⏩ MSG Sports → MSG Rangers: record date October 20, distribution October 26.
  • ⚠️ Barrick → North American Barrick: may slip to January 2027.
  • ⚠️ J&J → DePuy Synthes: reported Apollo sale talks at ≈$20B.
  • Unilever → Foods/McCormick: CMA Phase 1 formally opened September 16, statutory deadline November 11.
  • Eaton → Mobility + Dana: EC notification received September 16. Correction: Eaton’s July 31 Rule 425 filing already specified an exchange offer (split-off) with a pro-rata clean-up spin — August’s “election not made” was wrong.
  • Vivani → Cortigent: closing slipped to October 2026.
  • 🆕 Part 3 additions: Everus Construction (ECG), South Bow (SOBO), Amentum (AMTM).
  • Rating changes on completed names: OCTV BUY → HOLD (profile), VSNT HOLD → ACCUMULATE (price through the profile’s accumulate line).
  • Kraft Heinz (paused; moved its listing to NYSE September 14), Teleflex (converted to sales), Trump Media (paused — but its September 30 S-4 reopens a post-merger Truth Social spin), Microsoft → Xbox (Xbox’s CEO told the NYT “Xbox is not for sale”): not tracked as active spins.
  • Non-US monitored: ABF → Primark now dated December 2027; Jollibee → JFC International switched its listing venue from the US to Hong Kong; UPM → WISA completes October 31 (first trade November 2).

Part 1: Upcoming Spinoffs Overview (Next 12 Months)

IMMEDIATE OPPORTUNITIES (Next 30 Days)

Company (Ticker)SpinCo NameIndustryExpected DateStatusStructureKey Highlights
Corteva (CTVA)Vylor (VYLR) / New CortevaAg InputsOct 1, 2026 ✅ (completed after pricing)Form 10 effective Sep 24; record date Sep 24; injunction denied Sep 30Classic Spinoff1:1; $5,668M debt (2.26x gross); ≈$3.8B total cash to New Corteva; VYLR ≈$69 first close
Modine (MOD) / Gentherm (THRM)Performance Technologies → GenthermThermal MgmtOct 1, 2026 ✅ (completed after pricing)Vote passed Sep 10; IRS ruling receivedRMTTerms revised Sep 17: cash to Modine cut to $159M; $1.90 THRM special dividend; Modine → Modexus Solutions
MSG Sports (MSGS)MSG Rangers (MSGR)Pro SportsOct 26, 2026Record date Oct 20; WI from Oct 21Classic Spinoff · Dual-Class1 MSGR per 2 MSGS; MSGS → MSGK; ⚠️ NHL approval and Form 10 effectiveness outstanding
Medtronic (MDT)MiniMed (MMED) full exitDiabetes DevicesOffer expires Oct 9, 2026Exchange offer launched Sep 14Split-Off80.1% offered at a 7% discount; pricing Oct 5–7; clean-up spin/split if undersubscribed

Sort: within bucket, by investment grade (highest first).

Q4 2026 SPINOFFS (Nov–Dec)

Company (Ticker)SpinCo NameIndustryExpected DateStatusStructureRevenueKey Highlights
Barrick Mining (B)North American BarrickGold Mining⚠️ Year-end 2026 or January 2027No F-1 filed; CEO says may “slide into January”IPO Carve-Out · Retained Stake≈$5.2BFour Tier One assets; only 10–15% floated; NYSE primary / TSX secondary

Q1 2027 SPINOFFS (Jan–Mar)

Company (Ticker)SpinCo NameIndustryExpected DateStatusStructureRevenueKey Highlights
Genuine Parts (GPC)MotionIndustrial DistributionQ1 2027Leadership named Sep 9; investor day Dec 9Classic Spinoff≈$9BGPC’s CEO Will Stengel becomes Motion’s Chairman & CEO; $1.1B+ EBITDA; no Form 10 yet
Flex (FLEX)Axiom Solutions International (AXM)AI Data-Center Power / CoolingQ1 2027 (Form 10: “first half of 2027”)Form 10 filed Sep 15; EGM Nov 2Classic Spinoff · Retained Stake$6.6B (PF $7.0B)Sales +38%; $4.4B EPC Power purchase funded by Axiom debt; Flex keeps 6–12%; Flex CEO and CFO move to Axiom
Keurig Dr Pepper (KDP)Global Coffee CoCoffee / BeverageEarly 2027CEO named Oct 1 (post-pricing)Classic Spinoff≈$16BRuss Torres (ex-Kimberly-Clark) joins Nov 3; ≈4.5x net leverage
KBR (KBR)Trinzic (TZIC)Defense/Tech ServicesJan 4, 2027Form 10 filed Sep 30Classic Spinoff · Retained Stake$5.3B8.4% FY25 / 9.6% 1H26 standalone margin; $1.78B debt, $1.66B of it to KBR; KBR may keep up to 19.9%
Eaton (ETN)Mobility Group + DanaAuto ComponentsQ1 2027EC notified Sep 16RMT≈$11B combinedExchange offer (split-off) then merger; 8.3x PF EBITDA; ≈$1.1B cash to Eaton
International Paper (IP)EMEA PackagingPackagingQ1 2027No September developmentClassic Spinoff · Retained Stake · Dual-Listed≈$8.5BNYSE + LSE; IP retains 20% for 12–18 months

Q2–Q4 2027 SPINOFFS (Approaching / Just Beyond the 12-Month Window)

Company (Ticker)SpinCo NameIndustryExpected DateStatusStructureRevenueKey Highlights
Comcast (CMCSA)NBCUniversal (incl. Sky)Media/Entertainment≈Mid-2027Reaffirmed Sep 9; no public Form 10Classic Spinoff · Retained Stake≈$40B+CEO Mike Cavanagh; CMCSA retains up to 19.9% for up to 1 year; parent -18.3% in September on broadband
Unilever (UL)Foods → McCormick RMTFood / SpicesMid-2027CMA Phase 1 opened Sep 16 (deadline Nov 11)RMT≈$45B dealUL holders ≈65% / MKC ≈35%; Colman’s being sold separately
McKesson (MCK)Medical-Surgical Solutions (Wellverse)Healthcare Dist.H2 2027No September developmentIPO Carve-Out · Anchor Investor$11.4BApollo ≈13% stake; IPO then spin or split-off
J&J (JNJ)DePuy SynthesOrthopedics⚠️ H2 2027Apollo sale talks reported Sep 14Classic Spinoff≈$9.3BSpin still possible per WSJ; ≈$20B sale price reported
HF Sinclair (DINO)Lubricants & SpecialtiesLubricants≈H2 2027No September developmentClassic Spinoff≈$2.3BSupply agreements signed Aug 3
L3Harris (LHX)Missile Solutions (MSL)Defense/Missiles⚠️ Mid-2027No September developmentIPO Carve-Out · Retained Stake · Anchor Investor≈$3.6–3.8B$1B DoW convertible preferred; LHX retains ≈80%+
Textron (TXT)Industrial (Kautex + TSV)Industrial/MobilityQ2–Q3 2027No September development; sale or spinClassic Spinoff>$3BLeaves Textron pure-play A&D
Solventum (SOLV)Health Information SystemsHealth IT≈H2 2027No September developmentTBD≈$1.36BSpin, sale or combination all open

Sort: within bucket, by investment grade (highest first); ties broken by the Part 2 ranking.

EXPLORATORY / UNCERTAIN TIMING

Company (Ticker)SpinCo NameStatusStructureNotes
Adaptive Biotech (ADPT)Immune MedicinePath due by YE 2026TBDNo September development; ADPT +16.0% in September
National Fuel Gas (NFG)Seneca Resources + MidstreamBoard decision by Oct 15 (NEW)TBDStrategic review; spin is one of several options; ≈69% of NFG adjusted EBITDA
Spectrum Brands (SPB)Home & Personal CareConfidential Form 10 on fileClassic Spinoff · Anchor InvestorOaktree holds ≈27.3% of HPC since July 8; spin, sale or merger all live
Toro Corp. (TORO)AI OKTO Corp.Record date Oct 1 (NEW)Classic SpinoffMicro-cap footnote. Two LPG carriers + $45M cash; 1-for-8
Jet.AI (JTAI)Data Center Co. (DCTR)LOI Jul 14; no definitive agreementClassic SpinoffMicro-cap footnote. Non-binding; the 90-day window for a definitive agreement closes ≈mid-October
Vivani Medical (VANI)Cortigent HoldingsClosing slipped to OctoberTBDMicro-cap footnote. Via ClearOne merger; no distribution to VANI holders disclosed
Click Holdings (CLIK)Logistics DivisionNo September developmentTBDMicro-cap footnote. No terms disclosed

Summary: 21 active graded separations tracked over the next 12–15 months after two removals (New Fortress, ABVC) and no new large-cap announcement — September’s only new name is a strategic review (National Fuel Gas). The board is now front-loaded: four transactions complete or close inside October (Vylor and Modine/Gentherm on October 1, MiniMed’s exchange on October 9, MSG Rangers on October 26), and three Q1 2027 names (Trinzic, Axiom, Motion) produced their first primary disclosure of substance this month. Largest by revenue: Comcast/NBCUniversal (≈$40B+), KDP Global Coffee (≈$16B), McKesson Med-Surg ($11.4B), Eaton/Dana combined (≈$11B), Corteva ($9.9B seed). Highest quality: Corteva → Vylor (A-), which completed the day after pricing. The month’s theme is that filings cut both ways: Trinzic’s Form 10 showed lower margins and heavier extraction than the parent’s segment data implied, while Flex’s and GPC’s leadership decisions put the incumbent CEO on the SpinCo side — the strongest management signal in the methodology.


Part 2: In-Depth Analysis (Top-Tier & Imminent)

Upcoming Spinoffs — Ranked by Grade

All tracked upcoming separations, ranked by investment grade. Score is the weighted scorecard value (shown for the scored names); ★ is the quick visual tier mapped from grade.

RankParent (Ticker) → SpinCoGradeScore★ExpectedKey Thesis
1Corteva (CTVA) → Vylor (VYLR) / New CortevaA-3.80★★★★Oct 1, 2026 ✅Two scaled ag pure-plays; CEO to Seed; 2.26x gross leverage; completed the day after pricing
2Comcast (CMCSA) → NBCUniversalB+3.40★★★½≈Mid-2027Universal parks/studios + Peacock/Sky; 19.9% retained-stake overhang
3Genuine Parts (GPC) → MotionB+3.35★★★½Q1 2027#1 North American industrial MRO distributor; parent CEO moves to SpinCo (upgraded)
4Flex (FLEX) → Axiom (AXM)B+3.35★★★½Q1 2027AI data-center power, +38% growth; parent CEO moves to SpinCo; debt-funded EPC deal (upgraded)
5Barrick (B) → North American BarrickB+3.25★★★½⚠️ YE 2026 / Jan 2027Four Tier One gold assets; 10–15% float; may slip
6Modine/Gentherm (MOD/THRM) → Performance TechB+3.20★★★½Oct 1, 2026 ✅RMT closed the day after pricing; Modine becomes Modexus
7Keurig Dr Pepper (KDP) → Global Coffee CoB2.95★★★Early 2027≈$16B coffee scale; CEO named Oct 1 (post-pricing)
8KBR (KBR) → Trinzic (TZIC)B2.95★★★Jan 4, 2027Form 10: 8.4–9.6% margin, $1.66B to KBR, up to 19.9% retained (downgraded)
9MSG Sports (MSGS) → MSG Rangers (MSGR)B2.60★★★Oct 26, 2026Trophy NHL asset, no debt — loss-making and Dolan-controlled
10Eaton (ETN) → Mobility Group + DanaB—★★★Q1 2027RMT via exchange offer at 8.3x pro-forma EBITDA
11Unilever (UL) → Foods → McCormick RMTB—★★★Mid-2027≈$45B; CMA Phase 1 decision due Nov 11
12McKesson (MCK) → Medical-Surgical SolutionsB—★★★H2 2027$11.4B; Apollo 13% minority stake
13J&J (JNJ) → DePuy SynthesB—★★★⚠️ H2 2027≈$20B Apollo sale talks reported
14International Paper (IP) → EMEA PackagingB—★★★Q1 2027Dual NYSE+LSE; IP retains 20%
15HF Sinclair (DINO) → Lubricants & SpecialtiesB—★★★≈H2 2027≈$2.3B capital-light lubricants
16Medtronic (MDT) → MiniMed full exit (MMED)B-—★★½Oct 9, 2026Exchange offer at 7% discount; MiniMed growing 17%
17L3Harris (LHX) → Missile Solutions (MSL)B-—★★½⚠️ Mid-2027IPO postponed
18Textron (TXT) → Industrial (Kautex + TSV)B-—★★½Q2–Q3 2027Sale-or-spin still undecided
19Adaptive Biotech (ADPT) → Immune MedicineB-—★★½YE 2026 pathStructure TBD
20Solventum (SOLV) → Health Information SystemsB-—★★½≈H2 2027Structure undecided
21Spectrum Brands (SPB) → Home & Personal CareC+—★★IndefiniteSpin/sale/merger all live

Not ranked: National Fuel Gas (strategic review, decision by October 15); micro-cap footnotes Toro → AI OKTO, Jet.AI → DCTR, Vivani → Cortigent, Click Holdings → Logistics. Non-US monitored only: UPM → WISA, Tamarack/Headwater → Tributary.

Sort: by investment grade / weighted score, highest first. Ties broken by revenue (Motion ≈$9B ahead of Axiom $6.6B; Global Coffee ≈$16B ahead of Trinzic $5.3B). Removed this edition: New Fortress (completed Sep 11), ABVC/BioKey (completed Aug 21).

Deep-dive roster note: the eight deep-dives below are the six highest-graded upcoming names plus two promoted on new primary filings: KBR → Trinzic, whose Form 10 became public on the pricing date and moves the grade, and MSG Rangers, the next distribution after the two October 1 completions. Comcast’s section is short — nothing it filed changed. MiniMed’s exchange offer, though imminent, is covered in Part 2B: it is an exit from a stake already trading, analysed in Part 3. Deep-dives run in ranked order, with the promoted names last.


1. Corteva → Vylor (Seed) / New Corteva — ✅ completed October 1 (after pricing)

Executive Summary

  • Company: Corteva, Inc. (CTVA) — Price: $77.65 (Sep 30, 2026), -8.2% in September
  • SpinCo: Vylor, Inc. (NYSE: VYLR) — Seed; RemainCo New Corteva (Crop Protection) keeps CTVA
  • Industry: Agricultural Inputs — Completed: October 1, 2026, the day after this report’s pricing date
  • Structure: Classic Spinoff — Investment Grade: A- (Strong Opportunity)
  • Key Thesis: The highest-graded upcoming name went through on time, on the capital structure disclosed in August, with every remaining blank filled — and survived a multi-state legal challenge that came within a day of stopping it.

Transaction Overview

  • SpinCo (Vylor): Pioneer seed and genetics; $9.9B of FY2025 net sales. CEO Chuck Magro (Corteva’s sitting CEO); Chair Karen Grimes
  • RemainCo (New Corteva): crop protection chemistry and biologicals, ≈$7.8B; CEO Luke Kissam. Keeps legacy PFAS and EIDP environmental liabilities
  • Mechanics: board approval September 12; 1 VYLR per CTVA; record date September 24; distribution before the open October 1. Form 10 effective September 24, when-issued and ex-distribution trading cancelled the same day — so there were no pre-distribution prices for either half

What the final information statement (September 24) filled in

ItemAugust 14 amendmentFinal, September 24
Distribution ratioblank✅ 1 for 1
Record dateblank✅ September 24
Tickerblank✅ VYLR; New Corteva keeps CTVA
Debt at spin$5,577–5,579M✅ $5,668M ($3,143M short-term — mainly the PHI bridge, to be refinanced by revolvers — and $2,525M long-term)
Cash at spin$1,100M$1,100M
Cash to New Corteva≈$3,560M estimate✅ $726–776M at spin, plus ≈$3,078M already moved from Pioneer to EIDP since July 1 — ≈$3.8B in total
Dividend policy“to be populated”✅ Quarterly from Q4 2026, ≈15% of annual cash flow from operations
“Applicable Percentage”blank✅ Vylor 62% / New Corteva 38% of shared liabilities and shared separation costs

Leverage: 2.26x gross / 1.83x net on FY2025 pro-forma operating EBITDA of $2,503M, up marginally from 2.23x / 1.79x — the $91M increase is the larger exchange take-up and timing, not a change of plan. On the ≈$2.8B 2026 EBITDA Vylor guided at its September 15 investor day (secondary source; no deck filed) gross leverage is ≈2.0x.

The Applicable Percentage is the number to read twice. Vylor carries 62% of shared liabilities that cannot be assigned to either business — a larger share than its “seed is the crown jewel” positioning might suggest — but the filing is explicit that legacy PFAS and EIDP environmental liabilities stay with New Corteva. The indemnification chain this report described in August runs mostly to the RemainCo, which is what a buyer of Vylor would want.

The California challenge

In mid-September California, supported by 18 other states, the District of Columbia, Puerto Rico and nine subdivisions, sought leave in the District of South Carolina to enjoin the separation as a fraudulent transfer under California’s Uniform Voidable Transactions Act — the argument being that moving the seed business away from the entity carrying PFAS exposure defeats creditors. Leave was denied September 15; California appealed on September 18; the Fourth Circuit reversed and remanded, and on remand the District Court denied the injunction on September 30. Corteva’s board waived the “legal restraints” condition the same day. The distribution happened with roughly sixteen hours to spare. Separately, Corteva, Chemours and DuPont settled North Carolina’s PFAS claims for $455M over 15 years (Corteva’s share ≈$66M), and S&P cut Corteva’s unsecured rating A- → BBB+ on the spin (secondary).

Key Developments Since Last Report

  • Sep 9: North Carolina PFAS settlement ($455M over 15 years)
  • Sep 12 / 15: board approval; record date, ratio and ticker set; Form 10 Amendment No. 2; Vylor investor day (2029 targets: revenue $11.2–11.9B, EBITDA $3.3–3.7B, ≈30% margin — secondary)
  • Sep 21: Form 10 Amendment No. 3
  • Sep 24: Form 10 effective; when-issued trading cancelled; EIDP issued $700M of 6.000% notes due 2036 with a 101% special mandatory redemption if the spin failed
  • Sep 30: injunction denied; exchange offers closed at ≈$1,439M tendered, slightly above the $1,425M assumed
  • Oct 1 (post-pricing): distribution completed; VYLR first regular-way close ≈$69.00; CTVA ≈$12.06 (Yahoo; to be verified against the nightly series next edition)

Investment Scorecard

DimensionWeightScoreRationale
Financial Profile25%4$9.9B net sales at a 25.3% FY25 pro-forma operating EBITDA margin; $5,668M of debt against $1,100M cash = 2.26x gross / 1.83x net; ≈$3.8B to the parent in total, funded at an investment-grade-targeted structure
Competitive Position25%4Top-tier seed germplasm (Pioneer) with share leadership in North American corn and soy and across Latin America
Strategic Rationale20%4Clear focus-unlock; legacy PFAS stays with the RemainCo
Management & Governance20%4Sitting CEO moves to Seed (signal); full boards named
Acquisition Potential10%2Scale and antitrust limit acquirers
Weighted Score3.80
Investment GradeA-Strong Opportunity

Grade Change: A- (3.80) maintained. The grade is owned by the standing Vylor profile (pre-spin analysis, August 2026), and nothing in the final information statement contradicts it — every figure landed within a few percent of the August amendment. The California action is a lag-window event the profile did not know about; it was resolved before distribution and un-anchors no dimension, though Strategic Rationale’s “legacy liabilities stay behind” logic is now a litigated proposition and the profile’s post-spin pass should say so.

Recommendation: ⭐⭐⭐⭐ The participation call made in August is complete — holders of record on September 24 own both halves. The next decision is a valuation one on VYLR in its forced-selling window, which this report will make on the first post-spin data in the October edition.

Sources


2. Comcast → NBCUniversal

Executive Summary

  • Company: Comcast Corporation (CMCSA) — Price: $21.76 (Sep 30, 2026), -18.3% in September
  • SpinCo: NBCUniversal (including Sky) — Expected Completion: ≈Mid-2027
  • Structure: Classic Spinoff · Retained Stake — Investment Grade: B+ (Solid Opportunity)

Key Developments Since Last Report

  • Sep 9, Goldman Sachs Communacopia: CFO Jason Armstrong reaffirmed the mid-2027 split and said Peacock is profitable — and that broadband subscriber losses would not ease in Q3. CMCSA fell ≈7% that day; KeyBanc moved to Underweight (September 25) and UBS cut its target to $26–27, citing fiber competitors at $30–40 a month.
  • No public Form 10, no name or ticker, and no change to the up-to-19.9% retained stake.
  • What the decline means for this separation: the market is marking down the RemainCo — connectivity — not the media assets being spun. Versant, the read-across, fell 22.9% alongside, which says the market is not separating the two cleanly yet.

Investment Scorecard

DimensionWeightScoreRationale
Financial Profile25%4Universal parks/studios carry strong margins; Peacock now profitable per management
Competitive Position25%4Universal IP, top-tier theme parks, Sky footprint
Strategic Rationale20%3Clean thesis, but the up-to-19.9% retained stake defers full separation
Management & Governance20%3Cavanagh named; Form 10 pending
Acquisition Potential10%2Too large for most acquirers
Weighted Score3.40
Investment GradeB+Solid Opportunity

Grade Change: B+ (3.40) maintained. A CFO conference comment is not a filing; the broadband warning concerns the RemainCo.

Recommendation: ⭐⭐⭐ MONITOR. Nine months from distribution with no Form 10. The retained stake remains the single change that would move the score.

Sources


3. Genuine Parts → Motion — ⬆️ Upgraded on the CEO decision

Executive Summary

  • Company: Genuine Parts Company (GPC) — Price: $125.74 (Sep 30, 2026), -7.3% in September
  • SpinCo: Motion — industrial MRO and bearings/power-transmission distribution
  • RemainCo: Genuine Parts — NAPA and global automotive parts
  • Industry: Industrial Distribution — Expected Completion: Q1 2027
  • Structure: Classic Spinoff — Investment Grade: B+ (Solid Opportunity) ⬆️ (from B)
  • Key Thesis: The parent has answered the question the methodology weights most heavily — where the CEO goes — and it answered “the SpinCo.”

Transaction Overview

  • SpinCo (Motion): ≈$9B of sales and $1.1B+ of EBITDA (≈12%) — North America’s largest industrial MRO distributor
  • RemainCo (GPC): automotive aftermarket (NAPA, Europe, Asia-Pacific)
  • Rationale: two distribution businesses with different customers, cycles and capital needs; each re-rates against its own peer set (Applied Industrial, Fastenal, Grainger for Motion; AutoZone, O’Reilly for GPC)

Management Team (named September 9)

RoleMotion (SpinCo)Genuine Parts (RemainCo)
CEOWill Stengel — GPC’s current Chairman & CEO, becomes Motion Chairman & CEOCourt Carruthers — external (ex-TricorBraun CEO), CEO-elect from Sept 8
President / COOJames Howe (effective immediately)—
CFOHoward Yu (ex-Ball Corp. CFO)Bert Nappier (CFO & COO)
ChairWill StengelJean-Jacques Lafont (non-executive)

Analysis: GPC’s sitting CEO chose the industrial business and the parent hired an outsider for the larger automotive side. That is the clearest CEO-placement signal on the board this month, and it points the opposite way from the usual “parent keeps the CEO and the crown jewel” pattern. Motion also gets a public-company CFO from outside the GPC system.

Investment Scorecard

DimensionWeightScoreRationale
Financial Profile25%3≈$9B revenue at a ≈12% EBITDA margin, cyclical industrial end-markets; ⚠️ no Form 10, so separation debt and share count are undisclosed
Competitive Position25%4#1 North American industrial MRO/bearings distributor by revenue, dense branch network, scale purchasing
Strategic Rationale20%3Coherent separation of two unrelated distribution models; value unlock depends on Motion re-rating to industrial-distributor multiples
Management & Governance20%4 ⬆️Parent CEO moves to SpinCo; full C-suite named; compensation not yet disclosed (was scored on the missing-data default)
Acquisition Potential10%2A ≈$9B-revenue distributor has few buyers at this scale; §355(e) applies
Weighted Score3.35
Investment GradeB+Solid Opportunity

Grade Change: Upgraded B (unscored) → B+ (3.35), provisional. Trigger: the September 9 leadership announcement (8-K). Management moves off the missing-data default on a primary disclosure. Provisional on the Form 10, which will set the debt — the number this report has learned decides Financial Profile.

Recommendation: ⭐⭐⭐ ACCUMULATE GPC ahead of the Form 10. GPC is -7.3% in September and the December 8–9 investor days are the next disclosure event.

Acquisition Analysis (SpinCo)

Potential Acquirers: Grainger, Applied Industrial and Fastenal are the strategic logic; at Motion’s scale only Grainger could absorb it, with obvious antitrust overlap. Private equity (CD&R, which has bought industrial distributors) is the more plausible buyer after §355(e) lapses. Likelihood: Low near-term.

Sources


4. Flex → Axiom Solutions International (AXM) — ⬆️ Upgraded on the Form 10

Executive Summary

  • Company: Flex Ltd. (FLEX) — Price: $109.99 (Sep 30, 2026), +0.7% in September
  • SpinCo: Axiom Solutions International, Inc. (Nasdaq: AXM) — power and cooling infrastructure for AI data centers and the grid
  • Industry: Data-Center Power Infrastructure — Expected Completion: Q1 2027 (the Form 10 says “first half of calendar 2027”)
  • Structure: Classic Spinoff · Retained Stake — Investment Grade: B+ (Solid Opportunity) ⬆️ (from B)
  • Key Thesis: The fastest-growing SpinCo on the board, run by the parent’s own CEO and CFO — and loaded, before it trades, with the debt for a $4.4B acquisition the parent agreed to make.

Transaction Overview

  • SpinCo (Axiom): Flex’s power and cloud-infrastructure businesses, plus EPC Power once acquired
  • RemainCo (Flex): contract manufacturing; CEO Michael Hartung; new CFO Amy Schwetz (ex-Flowserve) from October 5
  • Mechanics: a pro-rata distribution in specie of 88.0–94.0% of Axiom through a Singapore court-approved capital reduction, intended to be tax-free. Flex retains 6–12% and intends to dispose of it within 24 months through debt-for-equity exchanges or further distributions. Requires a three-quarters shareholder vote at an EGM on November 2 and Singapore High Court approval. Ratio and record date blank

Financial Structure (Form 10, September 15)

ItemFigure
FY2026 net sales (to Mar 31, 2026)$6,614M, +38%
FY2026 operating income$480M (7.3% margin)
FY2026 net income$182M
Pro-forma net sales incl. EPC (FY2026 / Q1 FY27)$7,031M / $2,403M
Pro-forma interest expense (FY2026)$232M
Pro-forma short-term debt (Jun 26, 2026)$4,374M
Pro-forma long-term debt / cash$34M / $1,100M

The EPC Power deal is the separation-debt story. On September 3 Flex agreed to buy EPC Power for $4.4B cash (≈$800M of 2026 revenue, ≈40% organic growth expected in 2027, ≈30% 2027 EBITDA margin guided), funded by a 364-day bridge from Citi and BofA. EPC goes into Axiom, and Axiom borrows to pay Flex a “Spinco Cash Distribution” equal to Flex’s acquisition debt. The economic effect is that Axiom’s holders fund the acquisition and Flex is made whole. That is more benign than a classic debt dump — the debt buys a growing asset rather than paying the parent for nothing — but the purchase price is ≈5.5x EPC’s 2026 revenue, and Axiom has no say in it. Standalone EBITDA is not disclosed, so leverage cannot yet be computed; $4.4B against $480M of FY26 operating income before EPC is plainly heavy.

Investment Scorecard

DimensionWeightScoreRationale
Financial Profile25%3+38% revenue growth at a 7.3% operating margin, plus a ≈30%-margin acquisition; held at 3 by $4.4B of pro-forma debt and an undisclosed EBITDA ⚠️ provisional
Competitive Position25%4Scaled position in data-center power and liquid cooling at the center of the AI build-out; EPC adds grid-scale power conversion
Strategic Rationale20%3Separating a high-growth infrastructure business from contract manufacturing is a clear multiple unlock; marked down for the 6–12% retained stake and for the parent setting the SpinCo’s largest capital decision before independence
Management & Governance20%4 ⬆️Flex’s sitting CEO and CFO both move to Axiom, full C-suite and seven-member board named; compensation undisclosed (was 3)
Acquisition Potential10%2≈$7B+ revenue, §355(e), and a growth multiple make a takeout unlikely
Weighted Score3.35
Investment GradeB+Solid Opportunity

Grade Change: Upgraded B (unscored) → B+ (3.35), provisional. Triggers: the Form 10 (September 15) and the board/CFO 8-K. The CEO placement is the decisive fact; the score is capped by the debt the EPC structure loads. Provisional on standalone EBITDA, the ratio and the November 2 vote.

Recommendation: ⭐⭐⭐ ACCUMULATE FLEX into the record date, with the November 2 EGM as the gate and the November 10 Axiom Innovation Day as the first look at standalone economics. The ADI precedent applies: read the amended Form 10’s leverage before paying up for the growth.

Sources


5. Barrick → North American Barrick

Executive Summary

  • Company: Barrick Mining Corporation (B) — Price: $40.67 (Sep 30, 2026), -9.3% in September
  • SpinCo: North American Barrick — Carlin, Cortez and Turquoise Ridge (Nevada Gold Mines) plus Pueblo Viejo
  • Expected: ⚠️ year-end 2026, possibly January 2027
  • Structure: IPO Carve-Out · Retained Stake — Investment Grade: B+ (Solid Opportunity)

Key Developments Since Last Report

  • Sep 2: Bloomberg reported Barrick was weighing a delay to 2027 (secondary)
  • Sep 29: CEO Mark Hill said the IPO may “slide into January” but is still being pushed for year-end (secondary)
  • No F-1/S-1 filed with the SEC; no price range, ticker or change to the 10–15% float

Investment Scorecard

DimensionWeightScoreRationale
Financial Profile25%4≈$5.2B revenue from four Tier One assets at wide gold margins; ⚠️ no standalone financials filed
Competitive Position25%3Tier One orebodies, but a price-taking commodity
Strategic Rationale20%4Newmont settlement made the plan executable
Management & Governance20%3CEO Mark Hill and team named; comp undisclosed
Acquisition Potential10%185–90% retained — not acquirable
Weighted Score3.25
Investment GradeB+Solid Opportunity

Grade Change: B+ (3.25) maintained. A one-month slip is a timeline flag, not yet a red flag; a second slip, or no F-1 by November, would be.

Recommendation: ⭐⭐⭐ OWN THE PARENT, NOT THE FLOAT — unchanged.

Sources


6. Modine / Gentherm → Performance Technologies (RMT) — ✅ closed October 1 (after pricing)

Executive Summary

  • Companies: Modine (MOD) $187.20, +4.9% in September · Gentherm (THRM) $33.30, -15.2% in September
  • Structure: RMT — Investment Grade: B+ (Solid Opportunity)
  • Key Thesis: Every gate cleared in September; the transaction closed the day after pricing. The renegotiated terms moved value from Modine’s cash to Modine holders’ shares.

Key Developments Since Last Report

  • ✅ Sep 10 — Gentherm vote: share issuance 28,125,535 for / 8,725 against; charter amendment 28,950,597 for; 94.8% turnout. IRS private letter ruling received and all regulatory approvals obtained.
  • Sep 10: Modine will rename itself Modexus Solutions (ticker MOD unchanged), subject to a shareholder vote within three months of close
  • Sep 17 — terms revised: record date September 28; distribution and merger October 1. The exchange ratio was raised by ≈2.90M Gentherm shares; to offset it, SpinCo’s cash payment to Modine was cut from $210M to $159M and Gentherm pays a $1.90/share special dividend (≈$58.35M) to its own holders. Post-close ownership: Gentherm holders ≈56.4%, former SpinCo holders ≈43.6%
  • ⚠️ Still undisclosed: SpinCo standalone margins and the permanent SpinCo financing amount
DimensionWeightScoreRationale
Financial Profile25%3≈$2.6B combined revenue; SpinCo standalone margin and debt never separately disclosed
Competitive Position25%3Scaled thermal supplier in a price-pressured auto tier
Strategic Rationale20%4Modine becomes a pure-play climate/data-center cooling company
Management & Governance20%3Gentherm management runs the combination
Acquisition Potential10%3Thermal management consolidates steadily
Weighted Score3.20
Investment GradeB+Solid Opportunity

Grade Change: B+ (3.20) maintained. The revised terms are a reallocation between the two shareholder bases, not a change in what the business is.

Recommendation: ⭐⭐⭐ PREFER MODINE/MODEXUS — it took less cash and more of the combined company, and the RemainCo is the data-center-cooling pure-play. Gentherm fell 15.2% in September as its holders’ share of the combination was diluted. Both move to Part 3 next edition.

Sources


7. KBR → Trinzic (TZIC) — ⬇️ Downgraded on the Form 10 (promoted on new filing)

Executive Summary

  • Company: KBR, Inc. (KBR) — Price: $35.16 (Sep 30, 2026), -6.2% in September
  • SpinCo: Trinzic, Inc. (NYSE: TZIC) — Mission Technology Solutions (defense, space and intelligence services)
  • Expected Completion: January 4, 2027 (per KBR; the Form 10 says “[•], 2027”)
  • Structure: Classic Spinoff · Retained Stake — Investment Grade: B (Moderate / Hold) ⬇️ (from B+)
  • Key Thesis: The document this report flagged as missing for two editions arrived on the pricing date, and it describes a lower-margin, more heavily extracted SpinCo than the parent’s segment reporting implied.

What the Form 10 (September 30) disclosed

ItemWhat the report carriedForm 10
Margin basisKBR segment: 11.4% 1H26Standalone: 8.4% FY2025, 9.6% 1H26 (Q2 10.6%)
Revenue≈$5.8B (run-rate)$5,256M FY2025; $2,604M 1H26
Adjusted EBITDA$296M 1H26 (segment)$444M FY2025; $249M 1H26
Separation debtundisclosed$1,780M pro forma ($39M short-term, $1,741M long-term; notes, revolver, TLA and TLB)
Cash to KBRundisclosed$1,664M — 93% of the debt
Distribution100% assumed“At least 80.1%”; KBR may retain up to 19.9%, to be disposed of later, including via debt-for-equity exchanges
Ticker / CFO—TZIC; CFO Nicholas Veasey (ex-MAG Aerospace)

Leverage: ≈3.6x 1H26 annualised EBITDA, 4.0x FY2025. For a cost-plus government-services business at a high-single-digit margin that is at the top of the sector range, and almost all of it went to the parent. This is the ADI Global pattern — ≈$1.0B of debt at 3.14x on a 6.6% margin, most of it sent to Resideo — at larger scale. The 1.4–2.7-point gap between segment and standalone margin is the standalone corporate cost the segment never carried (the cost a standalone company carries that a parent’s segment never did).

Investment Scorecard

DimensionWeightScoreRationale
Financial Profile25%2 ⬇️8.4–9.6% standalone EBITDA margin with $1,780M of debt (≈3.6–4.0x) of which $1,664M is paid to KBR; improving quarterly margin (10.6% in Q2) is the offset (was 3)
Competitive Position25%3Credible defense/space services scale in a crowded, recompete-driven market
Strategic Rationale20%3 ⬇️The multiple-arbitrage logic stands, but the parent keeps up to 19.9% and takes 93% of the debt raised — the separation is financing KBR’s RemainCo as much as freeing Trinzic (was 4)
Management & Governance20%4External CEO (LaRouche, ex-Serco NA) and CFO named; firm date
Acquisition Potential10%3Federal services consolidates continuously; §355(e) and any retained stake delay it
Weighted Score2.95
Investment GradeBModerate / Hold

Grade Change: Downgraded B+ (3.40) → B (2.95). The trigger is the Form 10 filed September 30 — partly a data correction (the 11.4% margin was a segment figure and should not have been scored as the SpinCo’s) and partly new disclosure (debt, cash to parent, retained stake). Nothing happened to the business; what changed is that the report can now see the separation terms.

Recommendation: ⭐⭐⭐ HOLD KBR; do not buy for the Trinzic distribution. The more interesting security remains RemainCo KBR — the asset-light licensor at a ≈20% margin that receives $1.66B. Re-assess Trinzic in its post-spin window, and read the retained-stake disposal plan in the amended Form 10.

Sources


8. MSG Sports → MSG Rangers (MSGR) — ⚠️ distributes October 26 (promoted on imminence)

Executive Summary

  • Company: Madison Square Garden Sports Corp. (MSGS) — Price: $405.21 (Sep 30, 2026), +5.3% in September
  • SpinCo: MSG Rangers Corp. (NYSE: MSGR); RemainCo becomes MSG Knickerbockers (MSGK)
  • Structure: Classic Spinoff · Dual-Class — Investment Grade: B (Moderate / Hold)

Transaction Timeline

  • Aug 14: Form 10 public; amendments Sep 3, Sep 16, Sep 25, Sep 30
  • Sep 30: board approval
  • October 20, 2026: Record date ⚠️ DEADLINE TO OWN MSGS TO QUALIFY FOR MSGR
  • Oct 21: when-issued MSGR WI and ex-distribution MSGK WI trading begin
  • Oct 26, 11:59pm: distribution · Oct 27: regular-way MSGR and MSGK
  • ⚠️ Outstanding conditions: Form 10 effectiveness, NYSE listing, final NHL approval and a tax opinion

Key Developments Since Last Report

  • Ratio unchanged: 1 MSGR per 2 MSGS, Class A and Class B alike
  • Debt: a $250M Rangers revolver, undrawn, expiring November 2030, plus the $16.5M NHL advance — still essentially debt-free
  • Five directors, including Nelson Peltz, move to the MSGR board; Jamaal Lesane named EVP & Chief Legal Officer of MSG Sports (September 21)
DimensionWeightScoreRationale
Financial Profile25%2Pro-forma adjusted operating loss of $(16.3)M on $341.5M; $16.5M of debt
Competitive Position25%4Original Six NHL franchise in the largest US market
Strategic Rationale20%3Separates hockey from basketball economics; fourth Dolan separation of the same asset base
Management & Governance20%2James Dolan Executive Chairman and CEO of both successors; unlisted Class B control
Acquisition Potential10%1NHL approval plus Dolan control
Weighted Score2.60
Investment GradeBModerate / Hold

Grade Change: B (2.60) maintained. Dates set; nothing in the amendments changes a dimension. Peltz on the MSGR board is a governance positive that cannot overcome the Class B structure.

Recommendation: ⭐⭐⭐ OWN MSGS INTO OCTOBER 20 to receive both; treat MSGR as an asset-value holding. Watch for the NHL approval before the record date.

Sources


Part 2B: BRIEF UPDATES — OTHER TRACKED UPCOMING SPINOFFS

  • Keurig Dr Pepper → Global Coffee Co: No separation development inside September; KDP closed the $800M redemption of its Chobani stake and a $125M Allentown leasehold sale on September 28. ✅ October 1 (post-pricing): Russ Torres, President & COO of Kimberly-Clark, named Global Coffee CEO, joining November 3 and running the Coffee unit and JDE Peet’s integration under Tim Cofer until separation; Patsley chairs. No Form 10. (B (2.95) held as of the pricing date. The Management dimension, held at 2 for the open CEO search, is the first re-score next edition — an experienced external operator moves it to 3–4 and the grade toward B+.)
  • Eaton → Mobility + Dana (RMT): The European Commission received the merger notification on September 16. ⚠️ Correction: Eaton’s July 31 Rule 425 filing already specified separation by exchange offer (split-off), with a pro-rata clean-up spin if needed, and a straight spin if the RMT fails; last edition said the election had not been made. No S-4 or vote date. ETN +6.9%, DAN -8.9% in September. (B maintained.)
  • Unilever → Foods/McCormick RMT: ✅ The CMA formally opened its Phase 1 inquiry on September 16; statutory deadline November 11. McCormick reiterated a mid-2027 close (September 9) and is changing auditor from EY because EY will not be independent after closing; its October 1 Q3 release (post-pricing) says filings were “submitted on schedule across jurisdictions.” Colman’s sale (Rothschild) has no buyer yet. MKC -14.4% in September. (B maintained; November 11 is the next binary.)
  • McKesson → Medical-Surgical Solutions (Wellverse): No September development. IPO followed by a spin or split-off, H2 2027. (B maintained.)
  • J&J → DePuy Synthes: ⚠️ Bloomberg reported on September 14 that J&J is in talks to sell DePuy Synthes to Apollo for close to $20B, with other PE interest and a deal possible “within weeks”; the WSJ said a spin remains possible. J&J has said nothing. ≈$9.3B of 2025 sales. (B maintained, marked at risk of conversion to a sale — at which point it leaves the tracker, as Teleflex did.)
  • International Paper → EMEA Packaging: No September development. IP -12.5% in September. (B maintained.)
  • HF Sinclair → Lubricants & Specialties: No September development. (B maintained.)
  • Medtronic → MiniMed full exit: ⭐ Exchange offer launched September 14 — up to 225,361,295 MMED shares (80.1%) for MDT shares at a 7% discount (≈$107.53 of MMED per $100 of MDT), capped at 4.5939 MMED per MDT, with the remaining 27,452,053 shares added if oversubscribed; minimum condition 112,680,647 shares; pricing October 5–7, expiry October 9; any remainder by clean-up spin, split-off or debt-for-equity exchange. MiniMed’s Q1 FY27 net sales $843M (+17%, +16% organic), FY27 organic growth guidance raised to ≈10.5%; all nine covering analysts raised targets. The split-off ends the ≈90% overhang this report has blamed for MiniMed’s underperformance — but by replacing a static seller with a one-time wave of exchanged supply. Holders who tender MDT receive MMED at a discount; holders of MMED should expect pressure around the exchange. (B- maintained; the overhang thesis is tested in October.)
  • L3Harris → Missile Solutions: No September development. LHX -11.1%. (B- maintained.)
  • Textron → Industrial: No September development (no SEC filings at all). (B- maintained.)
  • Adaptive Biotechnologies → Immune Medicine: No September development; Morgan Stanley fireside chat September 15. ADPT +16.0%. (B- maintained; path due by year-end.)
  • Solventum → Health Information Systems: No September development; no bidders named. (B- maintained.)
  • Spectrum Brands → Home & Personal Care: No September development. Oaktree has held ≈27.3% of HPC since July 8 (FQ3 10-Q) — recorded this edition as an Anchor Investor feature. (C+ maintained.)
  • National Fuel Gas → Seneca Resources + Midstream (NEW, exploratory): Reported in mid-September as a strategic review of the ≈$5B upstream and gathering business (≈1.1 Bcf/d; ≈69% of NFG adjusted EBITDA) — sale, merger with a public producer, or spin — with a board decision due by October 15. Secondary sources only. Not graded until a structure is chosen.
  • Micro-caps: Toro → AI OKTO (NEW) — a 1-for-8 spin of two LPG carriers plus $45M of cash, record date October 1, distribution ≈October 8; Vivani → Cortigent — closing slipped to October, ClearOne raising $10–15M concurrently; Jet.AI → DCTR — no definitive agreement yet; Click Holdings → Logistics — nothing. Footnotes only.
  • Non-US monitored: UPM → WISA Group — completes October 31, first trade November 2; 2030 targets of >€550M sales and 13% comparable EBIT margin. ABF → Primark — December 2027. Jollibee → JFC International — now listing in Hong Kong rather than the US. Tamarack/Headwater → Tributary Exploration (NEW) — non-core assets spun alongside a ≈C$10B merger, Q4 2026.

Part 3: COMPLETED SPINOFFS — Extended Post-Spinoff Analysis

All prices as of September 30, 2026 close (verified daily data via yfinance). SpinCo returns vs the Day-1 reference basis fixed in prior reports (open or close as noted per name); post-spin low = lowest closing price since the first regular-way trading day. Returns are price returns and exclude dividends.

COMPLETED SPINOFFS SUMMARY TABLES

Table A: Overview & Ratings

TickerParentSpinCoSpinoff DateStatusSpinCo % Since SpinoffParent % Since SpinoffStructureRating
ADIGREZIADI Global DistributionAug 3-4, 2026NYSE-18.5% ↓REZI -30.6%Classic Spinoff⭐⭐⭐ B — HOLD
MFPMIDDMidera Food ProcessingJul 7, 2026Nasdaq+11.5%MIDD -25.6%Classic Spinoff⭐⭐⭐ B+ — HOLD
MBGLSPGIMobility GlobalJul 1, 2026NYSE-19.1% ↓SPGI -4.9%Classic Spinoff⭐⭐⭐⭐ A — BUY
HONAHONHoneywell AerospaceJun 29, 2026S&P 500 (Nasdaq)-29.6% ↓HON -7.4%Classic Spinoff · Multi-Way⭐⭐⭐ B+ — BUY
FDXFFDXFedEx FreightJun 1, 2026NYSE-26.9% ↓FDX -15.8%Classic Spinoff · Retained Stake⭐⭐⭐ B+ — HOLD
NVRIEnviriNew EnviriJun 1-2, 2026NYSE+1.7% (+$15/sh cash)Parent absorbedClassic Spinoff · Taxable · Paired Sale⭐⭐⭐ B — HOLD
OCTVHXGBFOctave IntelligenceMay 28, 2026Nasdaq NY + STO SDR-7.2%Hexagon +9.8%Classic Spinoff · Dual-Listed⭐⭐⭐ B — HOLD ⬇️
CHRNAPLDChronoScaleMay 5, 2026Nasdaq+49.2%APLD -38.9%RMT⚠️ SPECULATIVE
TRAXANABFirst Tracks BioApr 20, 2026Nasdaq+90.5%ANAB -1.4%Classic Spinoff⚠️ SPECULATIVE
VGNTAPTVVersigentApr 1, 2026NYSE+61.4%APTV -44.6%Classic Spinoff⭐⭐⭐⭐ B+ — BUY
JANDOCJanus LivingMar 20, 2026NYSE REIT+25.6% (+48.2% vs IPO)DOC -0.2% (vs IPO ref)IPO Carve-Out · REIT⭐⭐⭐ BUY
MMEDMDTMiniMedMar 6, 2026Nasdaq+2.2% (-2.7% vs IPO)MDT -7.7%IPO Carve-Out⚠️ SPECULATIVE
RNARNAAtrium TherapeuticsFeb 26, 2026Nasdaq-43.9% ↓Acquired by NovartisPre-Acquisition Spin⚠️ SPECULATIVE
WATBDXBD Biosciences RMTFeb 9, 2026CombinedN/A (RMT)BDX +9.8%RMT⭐⭐ HOLD
VSNTCMCSAVersantJan 5, 2026Nasdaq-29.8%CMCSA -21.7%Classic Spinoff · Dual-Class⭐⭐⭐ B — ACCUMULATE ⬆️
MICCULMagnum Ice Cream CoDec 6, 2025NYSE/Euronext/LSE+19.3%UL -1.7%Classic Spinoff⭐⭐⭐ HOLD
QDDQnityNov 3, 2025S&P 500+19.7%DD +25.9%‡Classic Spinoff⭐⭐⭐ A- — HOLD
SOLSHONSolsticeOct 30, 2025S&P 500+12.5%n/m†Classic Spinoff⭐⭐⭐ A- — HOLD
RALFTVRalliantJun 30, 2025NYSE+42.6%FTV +5.1%Classic Spinoff⭐⭐⭐ A- — HOLD
STRZLGFStarzMay 7, 2025Nasdaq+110.4%N/A (parent split)Parent Split⭐⭐⭐ HOLD
LIONLGFLionsgate StudiosMay 7, 2025Nasdaq+37.4%N/A (parent split)Parent Split⭐⭐⭐⭐ BUY
SNDKWDCSandiskFeb 24, 2025Nasdaq+3,480.0%WDC +827.1%Classic Spinoff⭐⭐⭐ B — HOLD
MRPLENMillrose PropertiesFeb 7, 2025NYSE REIT+10.6%LEN -31.9%Classic Spinoff · REIT⭐⭐⭐⭐ BUY
ECGMDUEverus ConstructionNov 1, 2024NYSE+123.9%MDU +22.8%Classic Spinoff⭐⭐⭐ B+ — HOLD (NEW)
SOBOTRPSouth BowOct 2, 2024NYSE / TSX+40.7%TRP +31.2%Classic Spinoff⭐⭐⭐ B — HOLD (NEW)
AMTMJAmentumSep 30, 2024NYSE-43.8%J +4.4%§RMT · Retained Stake⭐⭐⭐⭐ B — BUY (NEW)

Sort: by spinoff date, most recent first. All SpinCo returns vs Day-1 reference unless noted. Parent baselines are each parent’s first regular-way (ex-distribution) close. Everus (ECG), South Bow (SOBO) and Amentum (AMTM) are added this edition: each now carries a first grade from a full company profile, and a grade is not published until a report carries it; all three separated September–November 2024, which extends Part 3’s window back from February 2025. † Honeywell’s pre-breakup comparison remains n/m (3-way breakup + reverse split); HON is tracked from its Jun 29 post-spin close. ‡ DuPont split-adjusted for its 1-for-3 reverse split; raw quote $129.89. § Jacobs’ series carries a 1.010 provider adjustment factor (May 16, 2025); the return is computed on the adjusted series. Labels follow the site’s classification file this edition (first edition under the standardized vocabulary): ADIG no longer carries Anchor Investor and CHRN no longer shows the APLD stake in the label — see the note under Appendix B.

Table B: SpinCo Price Performance & Post-Spin Low Recovery (Updated September 30, 2026)

TickerDay 1 PricePost-Spin Low (close)Low DateDays to LowCurrent (Sep 30)vs Day 1vs Low
ADIG$22.00 (close, Aug 4)$17.92Sep 30, 202657$17.92-18.5%+0.0%
MFP$36.60 (close)$36.60Jul 7, 20260$40.82+11.5%+11.5%
MBGL$21.19 (close)$17.15Sep 30, 202691$17.15-19.1%+0.0%
HONA$220.19 (close)$151.58Sep 9, 202672$154.97-29.6%+2.2%
FDXF$149.53 (close)$109.38Sep 30, 2026121$109.38-26.9%+0.0%
NVRI$19.20 (close, Jun 2)$17.75Jun 3, 20261$19.53+1.7%+10.0%
OCTV≈$20.35 (open)$15.50Jul 23, 202656$18.89-7.2%+21.9%
CHRN$13.22 (close)$13.22May 5, 20260$19.73+49.2%+49.2%
TRAX$18.60 (close)$15.32Jun 3, 202644$35.44+90.5%+131.3%
VGNT$27.85 (close)$26.94Apr 7, 20266$44.94+61.4%+66.8%
JAN$23.60 (close)$22.88Mar 27, 20267$29.63+25.6% (+48.2% vs IPO)+29.5%
MMED$19.05 (open)$10.80May 15, 202670$19.47+2.2% (-2.7% vs IPO)+80.3%
RNA≈$14.75 (open)$8.19Sep 24, 2026210$8.28-43.9%+1.1%
VSNT$45.17 (open)$27.42Feb 12, 202638$31.70-29.8%+15.6%
MICC$14.90 (open)$13.06Apr 29, 2026141$17.78+19.3%+36.1%
Q$105.01 (open)$73.54Nov 24, 202521$125.74+19.7%+71.0%
SOLS$50.05 (open)$41.43Nov 18, 202519$56.32+12.5%+35.9%
RAL$48.49 (close)$38.39Feb 5, 2026220$69.17+42.6%+80.2%
STRZ$11.20 (close)$8.65Feb 5, 2026274$23.57+110.4%+172.5%
LION$8.15 (close)$5.59Jul 7, 202561$11.20+37.4%+100.4%
SNDK$48.60 (close)$29.62Apr 22, 202557$1,739.89+3,480.0%+5,774.0%
MRP$23.49 (open)$21.22Mar 11, 202531$25.97+10.6%+22.4%
ECG$52.49 (close, Nov 1)$33.60Apr 4, 2025154$117.52+123.9%+249.8%
SOBO$23.55 (close, Oct 8)¶$21.83Apr 8, 2025182$33.13+40.7%+51.8%
AMTM$32.25 (close, Sep 30)#$16.43Apr 8, 2025190$18.12-43.8%+10.3%

Sort: by spinoff date, most recent first. Post-Spin Low = lowest closing price since the first regular-way trading day; days are calendar days from the Day-1 date shown. New lows set in September: ADIG ($17.92, day 57), MBGL ($17.15, day 91) and FDXF ($109.38, day 121) — all three on the pricing date itself — plus HONA ($151.58, Sep 9, day 72) and RNA ($8.19, Sep 24, day 210). Five new lows in one month is more than any prior edition has recorded; three of them are names graded A or B+. ¶ South Bow’s anchor is its first NYSE regular-way close on October 8, 2024 — the profile corrected an earlier anchor on a pre-listing print (with dividends its return is materially higher; it is an income holding). # Amentum’s Day-1 close was an index-inclusion print — 41% of volume in the closing auction, +25.6% on the day, -20.2% the next session; the profile estimates the full-life return from a non-auction baseline at roughly -28%, in line with its peers.

Table C: SpinCo Performance Since Last Report (Aug 31 → Sep 30, 2026)

TickerAug 31 CloseSep 30 Close% ChangeCurrent Rating
RAL$61.73$69.17+12.1%⭐⭐⭐ A- — HOLD
SNDK$1,566.70$1,739.89+11.1%⭐⭐⭐ B — HOLD
CHRN$18.18$19.73+8.5%⚠️ SPECULATIVE
Q$119.43$125.74+5.3%⭐⭐⭐ A- — HOLD
ECG$115.13$117.52+2.1%⭐⭐⭐ B+ — HOLD (NEW)
JAN$29.75$29.63-0.4%⭐⭐⭐ BUY
LION$11.33$11.20-1.1%⭐⭐⭐⭐ BUY
HONA$158.11$154.97-2.0%⭐⭐⭐ B+ — BUY
MMED$20.26$19.47-3.9%⚠️ SPECULATIVE
VGNT$47.40$44.94-5.2%⭐⭐⭐⭐ B+ — BUY
OCTV$20.00$18.89-5.5%⭐⭐⭐ B — HOLD ⬇️
AMTM$19.99$18.12-9.4%⭐⭐⭐⭐ B — BUY (NEW)
STRZ$26.48$23.57-11.0%⭐⭐⭐ HOLD
SOLS$63.39$56.32-11.2%⭐⭐⭐ A- — HOLD
SOBO$37.77$33.13-12.3%⭐⭐⭐ B — HOLD (NEW)
NVRI$22.28$19.53-12.3%⭐⭐⭐ B — HOLD
MFP$46.88$40.82-12.9%⭐⭐⭐ B+ — HOLD
MICC$20.42$17.78-12.9%⭐⭐⭐ HOLD
MRP$30.42$25.97-14.6%⭐⭐⭐⭐ BUY
TRAX$41.84$35.44-15.3%⚠️ SPECULATIVE
MBGL$20.30$17.15-15.5%⭐⭐⭐⭐ A — BUY
ADIG$21.87$17.92-18.1%⭐⭐⭐ B — HOLD
FDXF$133.74$109.38-18.2%⭐⭐⭐ B+ — HOLD
VSNT$41.12$31.70-22.9%⭐⭐⭐ B — ACCUMULATE ⬆️
RNA$13.32$8.28-37.8%⚠️ SPECULATIVE

Sort: by % change since last report, best first. Five of twenty-five rose; the median name fell 11.0% while the S&P 500 fell 0.6% (SPY $767.05 → $762.63). Last month eleven of twenty-one rose. The winners were the AI-semiconductor and memory names (RAL, SNDK, Q) and one data-center contractor (ECG); the losers were spread across every structure and sector, and most had no company news — see the pattern analysis below. SOBO’s -12.3% includes going ex its $0.50 dividend on September 29.

Table D: Parent Company Performance Post-Spinoff

ParentTickerClose on Spinoff DateCurrent (Sep 30)% ChangeNotes
ResideoREZI$26.17 (Aug 4)$18.15-30.6%New CFO Sep 1; worst parent debut in the set
MiddlebyMIDD$139.26 (Jul 7)$103.58-25.6%Exiting Brewing & Distilling (Sep 9); guidance reaffirmed
S&P GlobalSPGI$414.97 (Jul 1)$394.47-4.9%-9.5% in September alongside MBGL
Honeywell TechnologiesHON$227.80 (Jun 29)$210.94-7.4%Q3 on Oct 22
FedExFDX$338.49 (Jun 1)$285.09-15.8%Holds ≈19.9% of FDXF; €2B + $1.1B notes priced Sep 9
HexagonHXGBF$9.00 (May 28)$9.88+9.8%Thin US OTC quote
Applied DigitalAPLD$39.88 (May 5)$24.37-38.9%Holds ≈97% of CHRN
AnaptysBioANAB$50.95 (Apr 20)$50.26-1.4%10-KT filed Sep 21
AptivAPTV≈$77.69 (pre-spin)$43.02-44.6%Worst tracked parent over the cycle
HealthpeakDOC≈$20 IPO ref$19.97-0.2%Retains majority of JAN
MedtronicMDT≈$93.46 (Mar 6)$86.29-7.7%MiniMed exchange offer live; FY27 guidance raised
BDBDX$163.04 (Feb 9)$179.00+9.8%Analyst day in November
ComcastCMCSA$27.80 (Jan 5)$21.76-21.7%-18.3% in September on broadband; spinning NBCUniversal
UnileverUL$61.80 (Dec 8)$60.73-1.7%*Foods/McCormick RMT pending
DuPontDD$34.38 (Nov 3)$43.30 (adj.)+25.9%‡1-for-3 reverse split Jun 24
Honeywell (pre-breakup)HON$197.94 (Oct 30)n/mn/m†Superseded by the Jun 29 baseline
FortiveFTV$52.13 (Jun 30 2025)$54.81+5.1%
Western DigitalWDC$49.02 (Feb 24 2025)$454.46+827.1%Called its 2028 converts Sep 14
LennarLEN$119.80 (Feb 7 2025)$81.59-31.9%FQ3 Sep 16: delivery target cut to 80–81K
MDU ResourcesMDU$15.10 (Nov 1 2024)$18.54+22.8%(NEW) Pure-play utility; Bakken East FID Sep 30
TC EnergyTRP$44.03 (Oct 2 2024)$57.78+31.2%(NEW) Kept the growing gas business
JacobsJ$129.60 (Sep 30 2024)$135.27+4.4%§(NEW) Sold its retained AMTM stake at a ≈17.5% discount

Sort: by spinoff date, most recent first. * UL share-consolidation adjusted. † Pre-breakup Honeywell line retained for continuity only. ‡ DD split-adjusted; raw $129.89. § Jacobs on the provider-adjusted series (1.010 factor, May 16, 2025). MDU’s baseline is its first ex-distribution close; the provider records the Everus distribution as a 1.805 factor on that date, so earlier MDU quotes in adjusted series are not prices at which MDU traded (the REZI convention).

Post-Spin Low Recovery — Pattern Analysis (updated)

  • September broke the liquidity-low pattern for the 2026 cohort, and it did it without news. ADIG, MBGL and FDXF all closed the month at new post-spin lows on the pricing date, on days 57, 91 and 121 — past the day-20-to-day-60 window in which every prior forced-selling trough in this dataset resolved. None had a company event in September: MBGL reaffirmed guidance at Goldman’s conference, ADIG’s CEO reiterated the plan at Jefferies, and FDXF’s news was an executive dismissal for conduct. A low that keeps making new lows past day 90 is not a forced-selling low. It is the market re-pricing the businesses — and in MBGL’s and FDXF’s case the parents fell in sympathy (SPGI -9.5%, FDX -12.9%), which points to sector multiples (information services; LTL freight) rather than anything separation-specific.
  • The two names with the clearest profile-driven views are now at their targets. ADIG ($17.92) sits at its $18 target; FDXF ($109.38) at its $108 target. In both cases the report moved to HOLD before the decline, on the filings. That is the useful outcome of reading the long record: the grade cuts came before the price did.
  • The retained-stake finding held, and the clearest test arrives in October. FDXF (19.9% retained) made a fifth consecutive monthly low. MMED (≈90%) is now inside an exchange offer that will release ≈80% of its float at a 7% discount on October 9 — the cleanest natural experiment this dataset will get on whether removing an overhang lifts the price or simply moves the supply.
  • Pre-acquisition spins are back to the base rate. RNA fell 37.8% — 20.9% on September 8 alone — with no announcement, to -43.9% vs Day 1, the worst return in the set. August’s IND and milestone news briefly made the structural argument look shaky; September put it back.
  • The only winners were tied to AI semiconductors and memory: RAL (+12.1%, now 19% above its target), SNDK (+11.1%), Q (+5.3%, joined the SOX index on September 21). Everything else fell. This was a month in which sector beta overwhelmed separation mechanics in both directions.

Per-name sections below are ordered by spinoff date, most recent first — the same rule as Tables A, B and D. Where a standing company profile exists, its grade and dimension scores are carried; the rating and target are the report’s, adjusted for the window between the profile’s price date and September 30.

1. ADI GLOBAL DISTRIBUTION (ADIG) ⭐⭐⭐ B — HOLD (re-scored B 2.80 → B 2.73)

  • Current Price: $17.92 (-18.1% in September; -18.5% vs the $22.00 Day-1 close). New post-spin low on the pricing date (day 57).
  • The profile (September 29, written against the $18.53 close) is now the grade. Its scorecard: Financial Profile 2.5, Competitive Position 3.0, Strategic Rationale 2.5, Management & Governance 3.0, Acquisition Potential 2.5 — 2.73, B, within band from the reports’ 2.80. Three findings drive it:
    • The $900M dividend ADI paid Resideo is the Honeywell indemnity bill, moved. Resideo paid Honeywell $1,590M in August 2025 to end its environmental indemnity, borrowing $1,225M to do it, and announced this separation the same day. ADI borrowed $1.0B at the spin and sent ≈$967M to its parent.
    • Underlying earnings are falling faster than the headline. Q2 standalone adjusted EBITDA of $86M included ≈$20M of one-time tariff refunds; without them it was ≈$66M, -31%, on volume down 2.4%. Underlying 2026 EBITDA is nearer $255–275M (≈5.3% margin).
    • The peak is behind it: an 8.7% segment operating margin in 2022; the Form 10’s three years start after it.
  • Lag window (Sep 28 → Sep 30): no company event; the stock fell a further 3.3% to a new low. CEO Rob Aarnes’s September 10 Jefferies appearance flagged tariffs, a weak residential AV market and ERP after-effects, with no guidance change.
  • Rating: HOLD. Target $18 — the price has reached it. The profile’s levels stand: what makes this a BUY is evidence, not price (gross margin ex-refunds up year on year, positive volume); below $14 the DCF needs only the 2023–25 margin back. Thesis-breaking: 2026 adjusted EBITDA below $240M.
  • ⚠️ Correction to the August 31 report (from the profile): August’s “segment adjusted EBITDA of $103M” was Resideo’s figure for its ADI segment, excluding ≈$17M a quarter of corporate cost; ADI’s own figure was $86M, $20M of it a one-time refund. August also presented exclusive brands’ rise to ≈18% of revenue as organic mix shift; almost all of it was the Snap One acquisition, and exclusive-brand revenue fell 2.7% in Q2.
  • Parent REZI $18.15 (-30.6%).
  • SEC — ADI Form 10-Q, quarter ended July 4, 2026
  • Investing.com — ADI Global Distribution at Jefferies Industrials Conference 2026 (transcript)

2. MIDERA FOOD PROCESSING (MFP) ⭐⭐⭐ B+ — HOLD

  • Current Price: $40.82 (-12.9% in September; +11.5% vs Day 1). Still has never closed below its debut.
  • No company development in September. The August 13 guidance raise (sales $935–965M, standalone adjusted EBITDA $160–176M) and $50M buyback stand. At $40.82 on ≈45.2M shares the market capitalisation is ≈$1.85B and EV ≈$2.15B — ≈12.8x the guided EBITDA midpoint, down from ≈14x a month ago on unchanged numbers.
  • Parent MIDD $103.58 (-25.6%) — on September 9 Middleby announced it is winding down its Brewing & Distilling group ($24M of 2025 sales, ≈$9M EBITDA loss) and reaffirmed guidance.
  • B+ — HOLD, with the entry improving. The buyback authorisation is the thing to watch for in the November print.

3. MOBILITY GLOBAL (MBGL) ⭐⭐⭐⭐ A — BUY

  • Current Price: $17.15 (-15.5% in September; -19.1% vs the $21.19 Day-1 close). New post-spin low on the pricing date (day 91).
  • What changed: the price, not the business. At Goldman’s Communacopia (September 10) management laid out a 7.5–10% medium-term organic growth target (core 5–7%, new products 1–2%, international 1–2%), said the 2025 margin of 40.6% resets to 39.1% on standalone costs with ≥50bp of expansion a year after, confirmed buybacks start in early 2027, and reported gross leverage of 2.7x / net 2.4x. FY26 guidance (revenue $1,870–1,885M, adjusted EBITDA $745–760M) is unchanged. CEO William Eager received a special grant of 126,072 RSUs on September 1. The first $0.06 dividend was paid.
  • SPGI fell 9.5% alongside — the decline looks like information-services de-rating rather than anything MBGL-specific.
  • Valuation at $17.15: ≈295.1M shares → $5.06B market cap; net debt ≈$1.80B → EV ≈$6.86B, ≈9.1x the guided FY26 EBITDA midpoint and ≈9.1% FY2025 free-cash-flow yield ($461M). The capital-returns arithmetic August set out — buying stock beats repaying 5.5% debt — is now ≈500bp wide, which makes the 2027 buyback start date harder to defend.
  • Grade A (4.35) maintained (profile, priced August 26; no new filings). ⭐⭐⭐⭐ BUY, target $28 — the lag window contains a price move, not an event. The profile’s re-test item: whether the 39.1% standalone margin disclosed at Goldman sits inside or below the ≈40% the FY26 guide implies — a Financial Profile question for the Q3 print (early November).
  • Investing.com — Mobility Global at Goldman Sachs conference (transcript)

4. HONEYWELL AEROSPACE (HONA) ⭐⭐⭐ B+ — BUY

  • Current Price: $154.97 (-2.0% in September; -29.6% vs Day 1). New post-spin low of $151.58 on September 9 (day 72), +2.2% off it.
  • Operations: at Jefferies (September 9) CEO Jim Currier called 2026 a “reset year” and reaffirmed the 6–8% growth outlook: backlog >$18B (+9%), book-to-bill >1.1, debt ≈$16B. 70 suppliers are critical or constrained, 10 severely — castings, forgings, complex machining and bearings; ≈$1B has gone into the supply base since 2023 with a similar amount planned faster. Nothing was said about receivables factoring or buyback execution — the two cash-flow items the profile flagged.
  • ⚠️ Governance, three items: (1) September 1 — a $2,042,518 DOJ False Claims Act settlement over NIST 800-171 cybersecurity compliance on a defense contract (2020–2023); (2) removed from the S&P 100 effective September 21; (3) a securities class action (class period June 29 – September 1, 2026) alleging the DOJ matter was not disclosed — lead-plaintiff deadline November 23.
  • Grade B+ (3.20) maintained; BUY, target $195. The settlement is immaterial in dollars. Scope for the profile’s next pass: the class action un-anchors Management & Governance (disclosure practice in the first quarter as a public company); nothing else moves. Q3 on October 28 settles the cash questions.
  • Parent HON $210.94 (-7.4%).
  • Levi & Korsinsky — Honeywell Aerospace class action notice
  • Investing.com — Honeywell Aerospace at Jefferies (transcript)

5. FEDEX FREIGHT (FDXF) ⭐⭐⭐ B+ — HOLD

  • Current Price: $109.38 (-18.2% in September; -26.9% vs Day 1). Fifth consecutive monthly new low, on the pricing date (day 121). Now at the $108 target set in August.
  • September 2 (8-K): FDXF dismissed Michael B. Lyons, EVP and Chief Specialized Services & Commercial Officer, after an internal investigation found Code of Conduct violations; the company says nothing touched financial reporting or customers. CTO Michael Rodgers took on the commercial role September 14. BofA cut its target to $140 (Buy) on weaker shipment expectations. No date set for the first calendarised (Q3) results, expected in October. No sale of FedEx’s 19.9% stake.
  • FedEx (FDX -12.9%) did not report a fiscal Q1 — it changed its year-end to December 31 — but priced €2.0B and $1.1B of notes on September 9.
  • Grade B+ (3.15) maintained (profile, priced August 25); HOLD, target $108 — the price has arrived at the target the long operating-ratio record supports. What would turn it: the operating ratio breaking below 85% for two quarters, or FedEx placing its stake at a clearing price.
  • SEC — FedEx Freight 8-K: executive separation (September 2, 2026)

6. NEW ENVIRI (NVRI) ⭐⭐⭐ B — HOLD

  • Current Price: $19.53 (-12.3% in September); +1.7% vs the June 2 regular-way close, plus the $15.00/share cash received separately. No filings and no development in September. B — HOLD.

7. OCTAVE INTELLIGENCE (OCTV) ⭐⭐⭐ B — HOLD ⬇️ (rating BUY → HOLD; first grade B)

  • Current Price: $18.89 (-5.5% in September); -7.2% vs the ≈$20.35 Day-1 open, +21.9% off its July low.
  • The profile (September 8, priced at $18.39) rebuilt the case on the audited three-year record, and it cuts the rating. The headline finding: Q2’s $2,134.7M of impairments against $398.4M of revenue were non-cash — the business produced $93.5M of free cash flow (23% margin) in the same quarter — and reported revenue (-1% organic) is suppressed by a licence-to-subscription transition (ARR +7% to $1,143M; deferred revenue +20.7%). But growth decelerated before the separation (4.1% → 1.3% → ≈0.7% guided), FCF margin has run 19.6% / 22.3% / 19.5%, and the DCF on the delivered margin gives $19.27; at management’s guided 20% it gives the market price.
  • Insiders bought: COO Michael Scott Moore 15,000 shares at $17.43 (September 11); Morgan Stanley initiated at Equal Weight, $21.
  • Grade: B — first letter grade. ⚠️ The profile scored Octave on a 10-point, five-part instrument (end market, competitive position, financial quality, capital allocation, valuation: 6.30/10), not the methodology’s 1–5 weighted scorecard, so there is no comparable weighted score. The letter is carried; a methodology re-score is an open item for the profile.
  • Rating: HOLD, target $19.50 (profile). Price is 3% below target; nothing in the lag window (Sep 8 → Sep 30) moved it. Upgrade trigger: a buyback announcement, or FCF margin sustained above 22%.
  • Parent Hexagon $9.88 (+9.8%).

8. CHRONOSCALE (CHRN) ⚠️ — SPECULATIVE

  • Current Price: $19.73 (+8.5%); +49.2% vs Day 1. A September 16 8-K extended its $2.0M B. Riley term loan to November 12 and pre-approved a sale of the legacy Ekso Bionics subsidiary; the November 6 annual meeting carries no reverse split or sale. APLD holds ≈97%; parent APLD $24.37 (-38.9%). SPECULATIVE.

9. FIRST TRACKS BIOTHERAPEUTICS (TRAX) ⚠️ — SPECULATIVE

  • Current Price: $35.44 (-15.3%); +90.5% vs Day 1. Three conferences, cash runway into Q2 2028 reiterated, no data. Parent ANAB $50.26 filed a transition 10-KT (Jemperli Q2 sales $331M, +26%). SPECULATIVE — trim into strength, not add.

10. VERSIGENT (VGNT) ⭐⭐⭐⭐ B+ — BUY

  • Current Price: $44.94 (-5.2%); +61.4% vs Day 1. First $0.13 dividend paid September 18; director Kevin Clark sold 122,722 shares ($5.7M) on September 8. Q3 on November 4. Parent APTV $43.02 (-44.6%). B+ (3.20) — BUY, target $62 maintained.

11. JANUS LIVING (JAN) ⭐⭐⭐ — BUY

  • Current Price: $29.63 (-0.4%); +25.6% vs Day 1 / +48.2% vs the $20 IPO. Revolver upsized from $500M to $1.25B (undrawn, SOFR + 105bp, March 2030) on September 17; Q4 monthly dividends of $0.0475 declared. The flattest month in the set. BUY.

12. MINIMED (MMED) ⚠️ — SPECULATIVE

  • Current Price: $19.47 (-3.9%); +2.2% vs the $19.05 open and back below the $20 IPO price (-2.7%).
  • Q1 FY27 (September 1): net sales $843M, +17% (+16% organic); FY27 organic growth guidance raised to ≈10.5%; MiniMed Fit submitted to FDA, Flex CE-marked, Vivera pivotal enrolment complete. All nine covering analysts raised targets.
  • The exchange offer (Part 2B) expires October 9. SPECULATIVE maintained until the post-exchange float is known; the October edition will be the first in which MiniMed trades as a fully separated company.

13. ATRIUM THERAPEUTICS (RNA) ⚠️ — SPECULATIVE

  • Current Price: $8.28 (-37.8% in September); -43.9% vs Day 1; new low $8.19 on September 24 (day 210).
  • No company announcement explains it. The stock fell 20.9% on September 8, the day of its Wells Fargo fireside chat, which repeated existing guidance (Corventis first patient by year-end 2026, data 2H27). The only other filings were inducement grants and RSU tax withholding. SPECULATIVE maintained — at ≈$264M of June 30 cash the market is now pricing the pipeline near zero, which is exactly what the pre-acquisition-spin argument predicts for an orphaned asset with long-dated catalysts.

14. WATERS (WAT) — BD BIOSCIENCES RMT ⭐⭐ HOLD

  • WAT $439.39 (+6.9%); no filings in September. Parent BDX $179.00 (+9.8%); analyst day with a new long-range plan in November. HOLD.

15. VERSANT (VSNT) ⭐⭐⭐ B — ACCUMULATE ⬆️ (first grade B 2.75; rating HOLD → ACCUMULATE)

  • Current Price: $31.70 (-22.9% in September); -29.8% vs the $45.17 Day-1 open, +15.6% off its February low.
  • The profile (September 10, priced at $37.36) gives Versant its first grade: B (2.75) — Financial Profile 3.0, Competitive Position 2.0, Strategic Rationale 3.5, Management & Governance 3.0, Acquisition Potential 2.0. Its central findings: revenue has declined ≈5% a year for three years, slowing to -2.5% in 1H26, while the price implied ≈11% a year; and Comcast took ≈$8.5B of cash out in three and a half years while spending ≈6 cents of capex per dollar of depreciation, then attached $3.2B of BB-rated debt. Brian Roberts’s Class B (0.26% of the economics) carries a veto over material transactions, which is why Acquisition Potential is 2.0.
  • Lag window (Sep 10 → Sep 30): no Versant event. The 15% further fall tracks Comcast’s broadband warning (CMCSA -18.3%), which is not Versant’s business, and a political item — MS NOW was among outlets barred from the White House grounds, and Versant joined a September 29 suit to block it.
  • Rating: HOLD → ACCUMULATE; target $42. The profile set the line explicitly: “Accumulate below $33, where the implied decline rate exceeds 14% and the free cash flow yield passes 24%.” The price crossed it on no company news. This is a price-driven rating change on the profile’s own terms, not a re-underwriting. Thesis-breaking items unchanged: FCF below $800M a year, or a dividend cut. Q3 in early November is the first full standalone quarter.
  • Parent CMCSA $21.76 (-21.7%).

16. MAGNUM ICE CREAM (MICC) ⭐⭐⭐ — HOLD

  • Current Price: $17.78 (-12.9%); +19.3% vs Day 1. A second LTIP forward-purchase programme of up to 6.6M shares (≈€110M) was launched September 18; a September 17 statement noted >20% of votes against the AGM’s growth-plan resolution. HOLD. Parent UL $60.73.

17. QNITY ELECTRONICS (Q) ⭐⭐⭐ A- — HOLD

  • Current Price: $125.74 (+5.3%); +19.7% vs Day 1.
  • Joined the PHLX Semiconductor Index (SOX) on September 21. The $455M North Carolina PFAS settlement (DuPont/Chemours/Corteva, over 15 years) leaves Qnity’s $43M indemnification liability unchanged.
  • A- (3.58) maintained; HOLD, target $132; accumulate below ≈$115. Price is between the two marks.
  • Parent DD $129.89 raw / +25.9%.

18. SOLSTICE ADVANCED MATERIALS (SOLS) ⭐⭐⭐ A- — HOLD

  • Current Price: $56.32 (-11.2% in September); +12.5% vs Day 1.
  • No filings after the August 27 termination. No buyback execution, guidance or refrigerant-pricing disclosure. Jefferies initiated at Buy, $86 (September 3).
  • The profile’s update (September 2, priced at $60.99) held A- (3.63) and cut the rating BUY → HOLD at a $62 target, because the termination’s upside had been captured at a standalone fair value of ≈$61 (range $55–69). The lag window gave back the entire termination pop — the shares are now 9% below target and near the bottom of the fair-value range. HOLD maintained; below $55 — the bottom of the profile’s range — it becomes a buy. The scheduled re-run of the DCF after Q3 decides it.

19. RALLIANT (RAL) ⭐⭐⭐ A- — HOLD

  • Current Price: $69.17 (+12.1% in September); +42.6% vs Day 1. No filings or developments.
  • A- (3.50) maintained; HOLD, target $58. ⚠️ The shares are now 19% above target and above the profile’s ≈$63 best-case sum of the parts. Do not add; this is a rating that would move to trim if the move holds into the Q3 print.

20. STARZ (STRZ) & LIONSGATE STUDIOS (LION) — PARENT SPLIT

  • STRZ: $23.57 (-11.0%); +110.4% from reference. Verizon Fios carriage expired at midnight September 30 and Starz went dark on Fios (post-pricing coverage); Alison Hoffman re-signed as President of Starz Networks through 2029. HOLD — a carriage loss is a direct revenue hit until resolved.
  • LION: $11.20 (-1.1%); +37.4% from reference. JPMorgan initiated at Underweight, $9 (September 25), putting the odds of a sale within 12 months at 20% against 30–40% it says is priced in. No new M&A reports since July. BUY maintained, with the takeover premium now explicitly contested.

21. SANDISK (SNDK) ⭐⭐⭐ B — HOLD

  • Current Price: $1,739.89 (+11.1%); +3,480.0% vs Day 1.
  • New $1.5B revolver to 2031 (September 9); Sandisk and Kioxia announced >$31B of planned Japan investment through 2032 (September 15; the new Kitakami Fab3 ≈$11.3B, 40% Sandisk, not operating before 2029). FQ1 guidance unchanged (revenue $10.3–10.8B, EPS $44–46). Parent WDC $454.46 (+827.1%) called its 2028 converts.
  • B (2.93) — HOLD, no target (profile). A multi-year capacity commitment at the top of a pricing cycle is the specific risk the profile named; it is now a disclosed one.

22. MILLROSE PROPERTIES (MRP) ⭐⭐⭐⭐ — BUY

  • Current Price: $25.97 (-14.6% in September); +10.6% vs Day 1.
  • Busy month: $1.0B of senior notes priced at par (September 22: $500M 6.500% 2029, $500M 6.750% 2031); revolver commitments raised to $1.385B; amended Lennar agreements; and a raised quarterly dividend of $0.79 (record October 5). Annualised, that is a ≈12.2% yield at $25.97.
  • Parent LEN $81.59 (-31.9%) cut its 2026 delivery target to 80–81K. The housing tape is what moved MRP; the land-bank model has not changed. BUY.

23. EVERUS CONSTRUCTION (ECG) ⭐⭐⭐ B+ — HOLD (NEW to this report; first grade B+ 3.18)

  • Current Price: $117.52 (+2.1% in September); +123.9% vs the $52.49 Day-1 close (November 1, 2024), +249.8% off its April 2025 low.
  • Why it is here: spun from MDU Resources on November 1, 2024 and carried as a backfill row; the profile (September 16, priced at $109.22) gives it a first grade.
  • The finding: the margin is re-estimation. Revenue rose 31.5% in 2025 and 30.0% organically in Q2 2026; backlog is $4.55B (+53%). But favorable changes in estimates on prior-period work added $75.7M to Q2 gross profit — 41% of it, $1.09 of $1.64 of EPS. Ex-catch-ups, operating margin fell from 5.1% (2023) to 2.9%. Eighteen years of MDU segment filings show operating income falling 47–59% in downturns.
  • Scorecard (profile): Financial Profile 3.0, Competitive Position 2.5, Strategic Rationale 4.0, Management & Governance 3.5, Acquisition Potential 3.0 → 3.18, B+.
  • September: closed the $295M Epsilon Industries acquisition (September 1) and amended its credit agreement; nothing after the profile’s date.
  • Rating: HOLD, target $97 — the price is 21% above target. Profile levels: do not add above $97; accumulate below $80. Dated: November 1, 2026 — the tax-matters restrictions on a sale and on buybacks expire.
  • Parent MDU $18.54 (+22.8%).

24. SOUTH BOW (SOBO) ⭐⭐⭐ B — HOLD (NEW to this report; first grade B 2.90)

  • Current Price: $33.13 (-12.3% in September, including the $0.50 ex-dividend on September 29); +40.7% vs the $23.55 first NYSE regular-way close (October 8, 2024).
  • Why it is here: spun from TC Energy on October 2, 2024; profile September 22 (priced at $35.10).
  • The finding: a toll road with a shortening lease. ≈90% of EBITDA contracted on Keystone, a 5.7% dividend covered at 57% of distributable cash flow, leverage 5.3x → 4.4x ahead of plan — but the whole return since listing is a re-rating (8.9x → 11.8x EBITDA) on EBITDA that has not grown ($1,091M → $1,022M, 2026 guided $1,040M). Weighted contract life has fallen from ≈8.7 to ≈7 years. Effective September 1 its own tariff filings cut the uncommitted Hardisty→Cushing toll from $12.76/$13.81 to $6.21/$6.75 per barrel, capping the spot upside. Against that, the Prairie Connector open season secured 465,000 bbl/d of 20-year commitments.
  • Scorecard (profile): 3.0 / 3.0 / 3.0 / 3.0 / 2.0 → 2.90, B.
  • Rating: HOLD, target US$33 — the price is at target. Accumulate below US$30. Dated: Q3 on November 4, the first period with the new tolls.
  • Parent TRP $57.78 (+31.2%).

25. AMENTUM (AMTM) ⭐⭐⭐⭐ B — BUY (NEW to this report; first grade B 2.73)

  • Current Price: $18.12 (-9.4% in September); -43.8% vs the $32.25 Day-1 close (September 30, 2024) — an index-inclusion auction print; see the Table B footnote.
  • Why it is here: the Jacobs RMT of September 2024; profile September 23 (priced at $19.70 after a one-cent correction).
  • The finding: a de-rating, not an earnings collapse. Adjusted EPS +22% since the spin, EBITDA +7%, leverage 4.10x → 3.03x, an 11.4% FCF yield — and the multiple went 16.0x → 8.1x. What justifies part of it: remaining performance obligations fell from $12.9B to $8.9B (-31%) while reported backlog is a record $48.2B. The tax-matters agreement barred any buyback, merger or change of control until September 28, 2026 — through a 47.5% drawdown.
  • Scorecard (profile): Financial Profile 3.0, Competitive Position 2.5, Strategic Rationale 2.0 (RMTs are the universe’s worst structure — 12 of 13 lagged the index), Management & Governance 3.0, Acquisition Potential 3.5 → 2.73, B.
  • Lag window (Sep 22 → Sep 30): the restriction lapsed on September 28 with no buyback announced; Amentum won a $572.4M Cheyenne Mountain systems contract and, through the OneAxIoM JV, preferred-supplier status on Sellafield’s up-to-£2.1B PACE Lot 1. The shares fell another 8% to $18.12. No event un-anchors a dimension.
  • Rating: BUY, target US$25 — a cheapness-and-catalyst call, not a quality call. Sell the thesis if RPO falls again in the late-November 10-K.
  • Parent Jacobs $135.27 (+4.4%).

Part 4: OUTLOOK & UPCOMING CATALYST CALENDAR

October 2026:

  • ✅ October 1 (the day after pricing): Corteva → Vylor (VYLR) distributed; Modine Performance Technologies → Gentherm RMT closed. Both move to Part 3 next edition — Vylor’s forced-selling window is the single most important price event of the month
  • October 5–9: MiniMed exchange offer — pricing October 5–7, final ratio by 9:00am October 8, expiry October 9
  • October 7: Gentherm’s $1.90 special dividend paid; Applied Digital fiscal Q1 call
  • ≈October 8: Toro → AI OKTO distribution (micro-cap)
  • By October 15: National Fuel Gas board decision on Seneca/Midstream — spin is one of the options
  • ⚠️ October 20: MSG Sports record date — the deadline to own MSGS for MSGR; ⚠️ final NHL approval still outstanding
  • October 22 / 28: Honeywell (HON) Q3; Honeywell Aerospace (HONA) Q3 on October 28 — the cash-conversion and factoring questions
  • October 26: MSG Rangers distribution; regular-way MSGR and MSGK October 27
  • October 31: UPM → WISA completes (non-US)
  • October: FedEx Freight’s first calendarised results; Vivani/Cortigent closing (micro-cap); Jet.AI’s 90-day window for a definitive agreement

November–December 2026:

  • November 1: Everus tax-matters restrictions on a sale and on buybacks lapse
  • November 2: Flex EGM on the Axiom capital reduction (three-quarters vote)
  • November 3–4: Russ Torres joins KDP; Versigent and South Bow Q3 (November 4)
  • Early November: Q3 prints for MBGL, MFP, ADIG, OCTV, VSNT, ECG — first full standalone quarters for ADIG and Versant’s first with a full quarter of interest
  • November 10: Axiom Innovation Day — first look at standalone economics
  • November 11: CMA Phase 1 deadline for Unilever Foods/McCormick
  • November 23: HONA class-action lead-plaintiff deadline
  • Late November: Amentum FY2026 10-K — remaining performance obligations decide the BUY
  • December 8–9: GPC and Motion investor days
  • By year-end: Barrick North American IPO (or January); Adaptive Biotechnologies separation path; J&J/DePuy spin-or-sale decision

2027:

  • January 4: KBR → Trinzic distribution
  • Q1: Eaton Mobility + Dana RMT (exchange offer); Flex → Axiom; Genuine Parts → Motion; International Paper EMEA; Keurig Dr Pepper Global Coffee (early 2027)
  • Mid: Comcast/NBCUniversal; Unilever/McCormick close; L3Harris Missile Solutions IPO
  • Q2–Q3: Textron Industrial (sale or spin)
  • H2: McKesson Medical-Surgical; HF Sinclair Lubricants & Specialties; Solventum Health Information Systems (structure TBD); ABF → Primark (December 2027, non-US)

Watch items / status changes this cycle:

  • ⬇️ KBR → Trinzic B+ (3.40) → B (2.95) on the Form 10: 8.4–9.6% standalone margin, $1.78B debt, $1.66B to KBR, up to 19.9% retained
  • ⬆️ Flex → Axiom B → B+ (3.35), provisional: Form 10 filed, parent CEO and CFO move to SpinCo, $4.4B EPC deal funded by SpinCo debt
  • ⬆️ Genuine Parts → Motion B → B+ (3.35), provisional: parent CEO moves to SpinCo
  • 🆕 First grades from profiles: ECG B+ (3.18) HOLD $97; SOBO B (2.90) HOLD $33; AMTM B (2.73) BUY $25; VSNT B (2.75); OCTV B (non-standard instrument — re-score pending)
  • ⬇️ OCTV BUY → HOLD, target $19.50 (profile) · ⬆️ VSNT HOLD → ACCUMULATE, target $42 (price through the profile’s $33 line)
  • ADIG re-scored B (2.80) → B (2.73) (profile); HOLD, target $18 — at target
  • ✅ Corteva/Vylor completed October 1 after the Fourth Circuit cleared California’s injunction attempt; A- (3.80) maintained
  • ✅ New Fortress Energy completed September 11 — shareholders got no BrazilCo shares; removed
  • ✅ ABVC/BioKey completed August 21 (correction); removed
  • ⏩ MiniMed exchange offer expires October 9; MSG Rangers record date October 20
  • ⚠️ Barrick IPO may slip to January; ⚠️ J&J in reported Apollo sale talks for DePuy
  • ⚠️ Five new post-spin lows (ADIG, MBGL, FDXF, HONA, RNA); ADIG and FDXF now at their targets
  • ⚠️ HONA: DOJ settlement, S&P 100 removal and a securities class action — a Management & Governance re-score item

APPENDIX A: COMPLETE SPINOFF LIST (September 2026)

#ParentSpinCoStructureFeaturesRevenueExpectedStatusGrade
1CortevaVylor (VYLR) / New CortevaClassic SpinoffNone$9.9B / $7.8BOct 1, 2026 ✅Completed the day after pricing; $5,668M debt, 2.26xA- ⭐
2ComcastNBCUniversalClassic SpinoffRetained Stake≈$40B+≈Mid-2027Form 10 pending; retains ≤19.9%B+
3Genuine PartsMotionClassic SpinoffNone≈$9BQ1 2027GPC CEO to Motion (Sep 9); no Form 10B+ ⬆️
4FlexAxiom (AXM)Classic SpinoffRetained Stake$6.6BQ1 2027Form 10 Sep 15; EGM Nov 2; Flex keeps 6–12%B+ ⬆️
5Barrick MiningNorth American BarrickIPO Carve-OutRetained Stake≈$5.2B⚠️ YE 2026 / Jan 2027No F-1; 10–15% floatB+
6Modine/GenthermPerformance Tech RMTRMTNone$2.6BOct 1, 2026 ✅Closed the day after pricingB+
7KDPGlobal Coffee CoClassic SpinoffNone≈$16BEarly 2027CEO named Oct 1 (post-pricing)B
8KBRTrinzic (TZIC)Classic SpinoffRetained Stake$5.3BJan 4, 2027Form 10 Sep 30; ≥80.1% distributedB ⬇️
9MSG SportsMSG Rangers (MSGR)Classic SpinoffDual-Class$341MOct 26, 2026Record date Oct 20; NHL approval pendingB
10EatonMobility Group + DanaRMTNone≈$11B combinedQ1 2027Exchange offer then merger; EC notifiedB
11UnileverFoods/McCormick RMTRMTNone≈$45B dealMid-2027CMA Phase 1 to Nov 11B
12McKessonMedical-Surgical (Wellverse)IPO Carve-OutAnchor Investor$11.4BH2 2027Apollo ≈13%B
13J&JDePuy SynthesClassic SpinoffNone≈$9.3B⚠️ H2 2027Apollo sale talks reported (≈$20B)B
14International PaperEMEA PackagingClassic SpinoffRetained Stake · Dual-Listed≈$8.5BQ1 2027IP retains 20%B
15HF SinclairLubricants & SpecialtiesClassic SpinoffNone≈$2.3B≈H2 2027No SpinCo leadership/Form 10B
16MedtronicMiniMed full exit (MMED)Split-OffNone$2.76BOct 9, 2026Exchange offer at 7% discountB-
17L3HarrisMissile Solutions (MSL)IPO Carve-OutRetained Stake · Anchor Investor$3.6–3.8B⚠️ Mid-2027IPO postponedB-
18TextronIndustrial (Kautex + TSV)Classic SpinoffNone>$3BQ2–Q3 2027Sale or spin undecidedB-
19Adaptive BiotechImmune MedicineTBD—Early-stageYE 2026 pathPath due by year-endB-
20SolventumHealth Information SystemsTBD—≈$1.36B≈H2 2027Structure undecidedB-
21Spectrum BrandsHome & Personal CareClassic SpinoffAnchor InvestorTBDIndefiniteOaktree ≈27.3% of HPCC+
22National Fuel GasSeneca Resources + MidstreamTBD—≈69% of NFG EBITDADecision by Oct 15Strategic review (NEW)—
23Toro Corp.AI OKTO Corp.Classic SpinoffNoneMicro-cap≈Oct 8, 2026Record date Oct 1 (NEW)—
24Jet.AIData Center Co. (DCTR)Classic SpinoffNoneMicro-capTBDNon-binding LOI—
25Vivani MedicalCortigent HoldingsTBD—Micro-capOct 2026Via ClearOne merger—
26Click HoldingsLogistics DivisionTBD—Micro-capTBDNo terms—

Sort: by investment grade (highest first), matching the Part 2 ranking; ungraded names last. In the Features column None = checked, no feature applies; — = not yet classifiable.

Completed / now-trading spinoffs and their full post-spin performance are tracked in Part 3, Tables A–D — not duplicated here.

Completed This Cycle: New Fortress Energy → BrazilCo/CoreCo (Sep 11; Distressed; removed — no SpinCo for shareholders); ABVC → BioKey (Aug 21; correction; removed). Completed October 1, after pricing: Corteva → Vylor; Modine → Gentherm.

Removed / Reclassified / Paused / Canceled:

  • ⚠️ Kraft Heinz → 2-way split: paused indefinitely (prior); listing moved to NYSE Sep 14
  • ⚠️ Teleflex → NewCo: converted to outright sales (prior)
  • ABB → ABB Robotics: SoftBank sale (prior)
  • WBD → Discovery Global: shelved (prior)
  • Topgolf Callaway: converted to a sale (prior)
  • CSL Seqirus: postponed indefinitely (prior)
  • Trump Media → Truth Social: paused June 10, 2026 — the September 30 S-4 for the TAE merger says the combined company “may pursue a spin-off… involving… Truth Social” after closing
  • Microsoft → Xbox: rumor only; Xbox CEO: “Xbox is not for sale”
  • Non-US separations monitored but not individually tracked: SoftBank → Roze, ABF → Primark (Dec 2027), Siemens Energy → Transformation of Industry, Baidu → Kunlunxin, Jollibee → JFC International (now Hong Kong), Evotec → Just Biologics, UPM → WISA Group (Oct 31, 2026), Tamarack/Headwater → Tributary Exploration (Q4 2026, NEW)

APPENDIX B: SPINOFF CLASSIFICATION REFERENCE

Every separation in this report carries one Structure — how the deal was done, legally and mechanically — and zero or more Features that modify it. Labels record the mechanics of each deal only. Definitions follow the Uncovering Value spinoff categories (vocabulary as of September 10, 2026).

Structure — exactly one per separation

StructureDefinitionDeciding questionIn this report
Classic SpinoffParent distributes SpinCo shares pro-rata to its shareholders as a dividend-in-kind and continues as a listed company. No merger, acquisition or restructuring is part of the separation. Typically tax-free under §355. No new capital. How much of SpinCo is distributed is a feature (Retained Stake), not part of the structure.Did every parent shareholder receive shares automatically, without electing?CTVA → Vylor, CMCSA → NBCUniversal, GPC → Motion, FLEX → Axiom, KDP → Global Coffee, KBR → Trinzic, MSGS → MSGR, JNJ → DePuy Synthes, IP → EMEA Packaging, DINO → Lubricants, TXT → Industrial, SPB → HPC, TORO → AI OKTO, JTAI → DCTR; ADIG, MFP, MBGL, HONA, FDXF, NVRI, OCTV, TRAX, VGNT, VSNT, MICC, Q, SOLS, RAL, SNDK, MRP, ECG, SOBO
IPO Carve-OutSpinCo sells a minority stake via IPO; parent keeps the majority (typically 80–90%). Raises capital, taxable at IPO, separation deferred.Was there an IPO, and did the parent still hold a majority afterwards?B → North American Barrick, MCK → Medical-Surgical, LHX → MSL; JAN, MMED
Split-OffShare-exchange tender — holders choose to swap parent shares for SpinCo shares.Did shareholders have to elect?MDT → MiniMed (full exit)
RMTReverse Morris Trust. The spun business simultaneously merges with an unrelated public company; both shareholder bases own the result.Did the SpinCo merge into an existing public company on day one?MOD → Performance Technologies/THRM, ETN → Mobility/Dana, UL → Foods/MKC; CHRN, WAT, AMTM
Parent SplitThe parent itself ceases to exist, dissolving into two or more successors. There is no RemainCo.Does the original listed entity still exist?STRZ, LION
Pre-Acquisition SpinA parent being acquired carves out an asset the acquirer does not want, before the deal closes.Was the parent itself under an agreed acquisition at the time?RNA
DistressedPart of a Chapter 11 or cross-border restructuring; creditors typically receive the higher-quality entity.Was the separation ordered or negotiated inside a restructuring?NFE → BrazilCo / CoreCo (completed this cycle)

Features — zero or more, on any structure

FeatureDefinitionIn this report
TaxableDistribution does not qualify for tax-free §355 treatment; holders taxed on receipt.NVRI
Paired SaleParent sells one business for cash at or near the same time as spinning another.NVRI
Retained StakeThe parent itself keeps a meaningful stake after the separation. A holder of the parent receiving its pro-rata shares does not count, however large.CMCSA → NBCUniversal, FLEX → Axiom, KBR → Trinzic, B → North American Barrick, IP → EMEA Packaging, LHX → MSL; FDXF, AMTM
Multi-WayThree or more successor entities, simultaneous or staged.HONA
Dual-ListedLists on two or more exchanges concurrently.IP → EMEA Packaging; OCTV
Dual-ClassUnequal voting rights, typically preserving family or founder control.MSGS → MSGR; VSNT
REITFormed or re-formed as a real estate investment trust.JAN, MRP
MLPFormed as a master limited partnership.—
Anchor InvestorA government, strategic partner or PE holder takes a position at or near separation.MCK → Medical-Surgical, LHX → MSL, SPB → HPC

TBD: an upcoming separation whose structure the company has not yet chosen. In Appendix A, None means checked and no feature applies; — means not yet classifiable.

Labelling notes for this edition (outside the template). This is the first edition labelled in the categories file’s vocabulary, and completed names take their labels from the site’s universe file. That changes three labels from August, beyond the retired tags (2-Way, 3-Way → Multi-Way, Pre-Acq Spin → Pre-Acquisition Spin):

  • ADIG loses Anchor Investor; CD&R’s preferred was issued to Resideo before the spin.
  • CHRN loses its “APLD ≈97%” annotation, and the universe file carries no Retained Stake for it.
  • VSNT gains Dual-Class.

The CHRN case is flagged for review: Applied Digital itself holds ≈97%, which reads as Retained Stake on the definition. Three upcoming labels are new this edition: Trinzic and Axiom take Retained Stake from their Form 10s, and Spectrum’s HPC takes Anchor Investor for Oaktree’s ≈27.3%.


Report Generated: October 1, 2026 (dated at its pricing date, September 30, 2026) Pricing: All stock prices as of the September 30, 2026 close (verified daily data via yfinance). The companion site’s nightly price series ran through September 29 at the time of writing, so September 30 closes were pulled directly; post-spin lows combine the nightly series with the direct September 30 bar. Next Update Recommended: Late October / early November 2026 — after the MiniMed exchange (October 9), the MSG Rangers distribution (October 26) and the HONA Q3 print (October 28), with the first month of Vylor and Gentherm/Modexus trading. Vylor’s first post-spin month is the highest-value event in the next edition: it is the first separation this report graded on fully disclosed leverage before the fact, and it will be the first real test of whether that discipline produces a better-than-average outcome. Methodology: Built primarily from company IR websites and SEC filings (Form 10 / 10-12B and amendments, final information statements, 8-K, S-4, Schedule TO, 10-Q, 10-K, 10-KT, DEF 14A, Rule 425), press releases and financial news, supplemented by “upcoming spinoffs” searches, an EDGAR sweep of every Form 10-12B and 10-12B/A filed in September, and the community trackers. Grades, dimension scores, ratings and targets for completed names are reconciled to the standing company profiles — new this cycle: Octave (Sep 8), Versant (Sep 10), Everus (Sep 16), South Bow (Sep 22), Amentum (Sep 23), ADI Global (Sep 29) and the Solstice update (Sep 2). For each, the window from the profile’s price date to September 30 was checked for events, and the report owns any rating change that resulted (VSNT). Primary filings were pulled directly from EDGAR for every name whose grade moved: the Trinzic Form 10; the Axiom Form 10, the EPC Power 8-K and Flex’s preliminary proxy; GPC’s leadership 8-K; and for Corteva, the final Vylor information statement, the board-approval and injunction 8-Ks and the exchange-offer results. Also pulled from EDGAR: MSG Sports’ board-approval 8-K and Form 10/A, Gentherm’s vote 8-K, Modine’s revised-terms release, Medtronic’s exchange-offer filings and NFE’s restructuring 8-K. The Investment Scorecard applies the five-dimension weighted framework (Financial 25%, Competitive 25%, Strategic 20%, Management 20%, Acquisition 10%; 1–5 per dimension) mapped to letter grades per the Spinoff Investment Analysis Skill methodology. Source: Spinoff Investment Analysis Skill v4.0


SOURCES

Completed Spinoffs — September 2026

Upcoming Spinoffs — Primary Sources

Completed-Spinoff Developments

Standing Company Profiles (Uncovering Value)

  • Octave Intelligence (Sep 8), Versant (Sep 10), Everus Construction (Sep 16), South Bow (Sep 22), Amentum (Sep 23), ADI Global (Sep 29), Solstice update (Sep 2), and the August profiles for Honeywell Aerospace, Mobility Global, FedEx Freight, Qnity, Versigent, Ralliant, Sandisk and Vylor

Online Community Corroborative Sources


DISCLAIMER

This report is for informational and educational purposes only. Not investment advice. Spinoff transactions are subject to change, delay, or cancellation — this cycle alone saw a multi-state injunction attempt against the year’s largest separation resolved the day before distribution (Corteva/Vylor), a SpinCo handed a $4.4B acquisition by its parent before it trades (Flex/Axiom), revised merger terms three weeks before closing (Modine/Gentherm), a reported sale negotiation overtaking a planned spin (J&J/DePuy Synthes), and a restructuring in which shareholders received none of the spun business (New Fortress Energy). Stock prices referenced are as of the September 30, 2026 close (verified daily data via yfinance).

Where a parent has undergone a corporate action that distorts comparison, this is footnoted and the affected figures are shown adjusted or marked “n/m”. This edition adds MDU Resources (provider adjustment factor 1.805 on the Everus distribution date) and Jacobs (a 1.010 provider factor, May 2025). It also adds New Fortress Energy’s 1-for-50 reverse split, under which the $0.29 August 31 quote corresponds to ≈$14.50 split-adjusted.

Corrections recorded in this edition.

  • ADI Global: August’s “segment adjusted EBITDA of $103M” was Resideo’s segment figure; ADI’s standalone figure was $86M, including a ≈$20M one-time tariff refund. The exclusive-brand mix shift August credited as organic was mostly the Snap One acquisition. (Source: the ADI profile.)
  • KBR/Trinzic: the 11.4% margin carried in August was KBR’s segment figure; Trinzic’s standalone margin is 9.6% (1H26) and 8.4% (FY2025). This is a data correction as well as new disclosure, and it is one reason for the downgrade.
  • Eaton/Dana: the separation method (exchange offer, with a clean-up spin) was disclosed on July 31, not left open as August stated.
  • ABVC/BioKey: the distribution completed August 21; August listed it as unconfirmed.
  • New Fortress Energy: Chapter 15 recognition was June 29, 2026 per the company’s own 8-K, not July 14.

Grade changes in this edition rest on primary documents filed this cycle. Trinzic’s downgrade rests on its Form 10. Axiom’s and Motion’s upgrades rest on a Form 10 and on leadership 8-Ks that place the parent’s sitting CEO at the SpinCo. The five first grades and ADI’s re-score come from company profiles built from 10-Ks and 10-Qs. Two upgrades (Axiom, Motion) are provisional: Axiom’s standalone EBITDA, distribution ratio and shareholder vote are pending, and Motion has no Form 10. Barrick’s IPO timing, J&J’s spin-or-sale choice, National Fuel Gas’s review and the MSG Rangers NHL approval are all unresolved at the pricing date. Always conduct your own due diligence and consult with financial advisors before making investment decisions. Past spinoff performance does not guarantee future results.